JA

Profile

Research

Social

Other

Hirano Kenichi

平野 賢一

Graduate School of Medicine, Specially Appointed Professor (Full Time)

keyword Triglyceride deposit cardiomyovasculopathy(TGCV),Cardiovascular disease,Atherosclerosis

Education

  • - 1985, Nagoya University, School of Medicine

Research History

  • 2021/02 - Present, Osaka University
  • 2005/07 - 2021/01, 大阪大学大学院医学系研究科循環器内科(診療科再編に伴い所属変更)
  • 2004/11 - 2009/03, 大阪大学医学部附属病院 循環器内科 病棟医長
  • 2000/11 - 2005/03, -: - Osaka University, Research Assistant
  • 1997/09 - 2000/10, 大阪大学医学部附属病院 医員
  • 1994/05 - 1997/08, 米国シカゴ大学に留学 (Research Associate)
  • 1992/07 - 1994/04, 大阪大学医学部附属病院 医員
  • 1988/07 - 1992/06, 大阪大学医学部第2内科
  • 1986/01 - 1988/06, 市立豊中病院 内科勤務
  • 1985/06 - 1985/12, 大阪大学医学部第2内科に入局 大阪大学医学部附属病院にて臨床研修

Research Areas

  • Life sciences, Metabolism and endocrinology
  • Life sciences, Cardiology
  • Life sciences, Pathobiochemistry

Professional Memberships

  • American Heart Association
  • Japanese College of Cardiology
  • Society for Triglyceride Biology and Medicine
  • 日本内科学会
  • 日本循環器学会
  • 日本動脈硬化学会
  • 日本心不全学会
  • American Society of Biochemistry and Molecular Biology
  • 日本臨床分子医学会
  • THE JAPANESE BIOCHEMICAL SOCIETY
  • Japanese Society for Medical Use of Functional Foods
  • Japanese Society for Clinical Nutrition and Metabolism
  • JAPAN SOCIETY OF CLINICAL CHEMISTRY
  • 日本病理学会

Papers

  • A novel homozygous missense mutation in PNPLA2 in a patient manifesting primary triglyceride deposit cardiomyovasculopathy, Yasuhiro Hara,Yoshihiko Ikeda,Hayato Kimura,Shinsaku Shimamoto,Mao Ishikawa,Kunihisa Kobayashi,Hironori Nagasaka,Hisashi Shimoyama,Ken-ichi Hirano, Molecular Genetics and Metabolism Reports, Vol. 34, 2023/02
  • Tricaprin can prevent the development of AAA by attenuating aortic degeneration, Hirona Kugo,Yuki Sugiura,Rena Fujishima,Shintou Jo,Hirotaka Mishima,Erina Sugamoto,Hiroki Tanaka,Satoshi Yamaguchi,Yoshihiko Ikeda,Ken-Ichi Hirano,Tatsuya Moriyama,Nobuhiro Zaima, Biomed Pharmacother, Vol. in press, 2023
  • Remarkable regression of diffuse coronary atherosclerosis in patients with triglyceride deposit cardiomyovasculopathy, Ken-ichi Hirano,Masahiro Higashi,Kenichi Nakajima, European Heart Journal, Oxford University Press (OUP), Vol. in press, 2022/12/30
  • Methods of calculating 123I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy, Chen Z,Nakajima K,Hirano K,Kamiya T,Yoshida S,Saito S,Kinuya S, Ann Nucl Med, Vol. 36, No. 11, p. 986-997, 2022/11
  • Modified Algorithm Using Total Count for Calculating Myocardial Washout Rate in Single-Photon Emission Computerized Tomography, Miyauchi H,Ono R,Iimori T,Sawada K,Hoshi K,Hirano K,Kobayashi Y, Ann Nucl Cardiol, Vol. in press, 2022/09
  • A near-infrared fluorescent long-chain fatty acid toward optical imaging of cardiac metabolism in living mice, Swamy MMM,Zubir MZM,Mutmainah,Tsuboi S,Murai Y,Monde K,Hirano K,Jin T, Analyst, Royal Society of Chemistry (RSC), Vol. 147, No. 19, p. 4206-4212, 2022/09
  • 123I-BMIPP scintigraphy shows that CNT-01(tricaprin) improves myocardial lipolysis in patients with idiopathic triglyceride deposit cardiomyovasculopathy: First randomized controlled, exploratory trial for TGCV, Miyauchi H,Hirano K,Nakano Y,Shimada K,Nishikawa M,Yamamoto H,Nakamura A,Miyake A,Aoshima C,Fujimoto S,Nakatani D,Yamada T,Amano T,Nakajima K, Ann Nucl Cardiol, Vol. 8, No. 1, p. 67-75, 2022/08
  • Clinical significance of 123I-BMIPP washout rate in patients with uncertain chronic heart failure, Aoshima C,Fujimoto S,Kudo A,Kawaguchi Y,Takamura K,Matsue Y,Kato T,Kawamura Y,Kimura S,Kamo Y,Nozaki Y,Takahashi D,Tomizawa N,Hiki M,Kasai T,Nojiri S,Miyauchi H,Hirano K,Shimada K,Murakami K,Minamino T, Eur J Nuc Med Mol Imaging, Vol. 49, No. 9, p. 3129-3139, 2022/03
  • Genetic deficiency of adipose triglyceride lipase is associated with a novel type of podocytopathy, Nagasawa Y,Okumura T,Hara Y,Kondo T,Hasegawa M,Ikeda Y,Murohara T,Hirano K, Kidney International Reports, Vol. 6, No. 10, p. 2722-2725, 2021/10
  • Triglyceride Deposit Cardiomyovasculopathy with Massive Myocardial Triglyceride which was Proven Using Proton-magnetic Resonance Spectroscopy, Eiryu Sai,Kazunori Shimada,Tatsuro Aikawa,Chihiro Aoshima,Kazuhisa Takamura,Makoto Hiki,Takayuki Yokoyama,Tetsuro Miyazaki,Shinichiro Fujmoto,Hakuoh Konishi,Ken-ichi Hirano,Hiroyuki Daida,Tohru Minamino, Internal Medicine, Japanese Society of Internal Medicine, Vol. 60, No. 8, p. 1217-1220, 2021/04
  • Outside-in signaling by femoral cuff injury induces a distinct vascular lesion in adipose triglyceride lipase knockout mice, Hirotsugu Noguchi,Sohsuke Yamada,Ken-Ichi Hirano,Satoshi Yamaguchi,Akira Suzuki,Xin Guo,Nobuhiro Zaima,Ming Li,Kunihisa Kobayashi,Yoshihiko Ikeda,Toshiyuki Nakayama,Yasuyuki Sasaguri, Histol Histopathol, Vol. 36, No. 1, p. 91-100, 2021/01
  • Prevalence and clinical outcomes of triglyceride deposit cardiomyovasculopathy among haemodialysis patients, Onishi T,Nakano Y,Hirano K,Nagasawa Y,Niwa T,Tajima A,Ishii H,Takahashi H,Sakurai S,Ando H,Takashima H,Amano T, Heart, Vol. 107, No. 2, p. 127-134, 2021/01
  • Effect of tricaprin on cardiac proteome in a mouse model for triglyceride deposit cardiomyovasculopathy, Hara Y,Zhang B,Suzuki A,Yamaguchi S,Adachi J,Tomonaga T,Yasunaga S,Saku K,Aoyama T,Hirano K, J Oleo Sci, Vol. 69, No. 12, p. 1569-1577, 2020/12
  • Aortic insufficiency associated with Impella that required surgical intervention upon implantation of the durable left ventricular assist device, Hideo Oishi,Toru Kondo,Kazuro Fujimoto,Masato Mutsuga,Ryota Morimoto,Ken-ichi Hirano,Akinori Sawamura,Shingo Kazama,Yuki Kimura,Naoki Shibata,Hiroo Kato,Yoshihito Arao,Tasuku Kuwayama,Shogo Yamaguchi,Hiroaki Hiraiwa,Takahiro Okumura,Akihiko Usui,Toyoaki Murohara, Journal of Artificial Organs, Springer Science and Business Media LLC, Vol. 23, No. 4, p. 378-382, 2020/12
  • The Diagnostic Criteria 2020 for Triglyceride Deposit Cardiomyovasculopathy., Kobayashi K,Sakata Y,Miyauchi H,Ikeda Y,Nagasawa Y,Shimada K,Nakajima K,Kozawa J,Hao H,Amano T,Yoshida H,Inaba T,Hashimoto C,Hirano K, Annals of Nuclear Cardiology, Vol. 6, No. 1, p. 99-104, 2020/08
  • Correlation perspectives for the diagnosis of idiopathic triglyceride deposit cardiomyovasculopathy, Miyauchi H,Iimori T,Hoshi K,Ohyama M,Hirano K,Kobayashi Y, Annals of Nuclear Cardiology, Vol. 6, No. 1, p. 33-38, 2020/08
  • Association of Triglyceride Deposit Cardiomyovasculopathy With Drug-eluting Stent Restenosis Among Patients With Diabetes, Nakano Y,Suzuki M,Hirano K,Ando H,Takashima H,Takahashi H,Amano T, JAMA Network Open, Vol. 3, No. 8, 2020/08
  • Levitating Cells to Sort the Fit and the Fat, Nazan Puluca,Naside Gözde Durmus,Soah Lee,Nadjet Belbachir,Francisco X. Galdos,Mehmet Giray Ogut,Rakhi Gupta,Ken‐ichi Hirano,Markus Krane,Rüdiger Lange,Joseph C. Wu,Sean M. Wu,Utkan Demirci, Advanced Biosystems, Wiley, Vol. 4, No. 6, p. 1900300-1900300, 2020/06
  • A historical case of primary triglyceride deposit cardiomyovasculopathy, Tanaka M,Ikeda Y,Li M,Zaima N,Kawahara Y,Watanabe K,Inaba T,Kobayashi K,Noguchi H,Yamada S,Hao H,Hirano K, Pathology International, Vol. 70, p. 58-61, 2019/11
  • Increased Washout of 123IBMIPP in Triglyceride Deposit Cardiomyovasculopathy (TGCV) with Severe Coronary Stenosis -A Pitfall of Diagnosis for TGCV-, Hirano K,Higashi M,Miyauchi H,Takagi A,Ikeda Y,Nakano Y,Amano T, Annals of Nuclear Cardiology, Vol. 5, No. 1, p. 47-49, 2019/08
  • Development of a simultaneous quantitation for short-, medium-, long-, and very long-chain fatty acids in human plasma by 2-nitrophenylhydrazine-derivatization and liquid chromatography–tandem mass spectrometry, Zhen Chen,Zijun Gao,Yue Wu,Rojeet Shrestha,Hiromitsu Imai,Naoto Uemura,Ken-ichi Hirano,Hitoshi Chiba,Shu-Ping Hui, Journal of Chromatography B, Vol. 1126-1127, 2019/08
  • Detection of Jordans’ anomaly using compact-type automated hematology analyzer, Inaba T,Okumura K,Fujita N,Suzuki A,Hirano K, International Journal of Hematology, Vol. 110, No. 2, p. 129-130, 2019/06
  • Triglyceride Deposit Cardiomyovasculopathy: A Rare Cardiovascular Disorder, Ming Li,Ken-ichi Hirano,Yoshihiko Ikeda,Masahiro Higashi,Chikako Hashimoto,Bo Zhang,Junji Kozawa,Koichiro Sugimura,Hideyuki Miyauchi,Akira Suzuki,Yasuhiro Hara,Atsuko Takagi,Yasuyuki Ikeda,Kazuhiro Kobayashi,Yoshiaki Futsukaichi,Nobuhiro Zaima,Satoshi Yamaguchi,Shrestha Rojeet,Hiroshi Nakamura,Katsuhiro Kawaguchi,Eiryu Sai,Shu-Ping Hui,Yusuke Nakano,Akinori Sawamura,Tohru Inaba,Yasuhiko Sakata,Yoko Yasui,Yasuyuki Nagasawa,Shintaro Kinugawa,Kazunori Shimada,Sohsuke Yamada,Hiroyuki Hao,Daisaku Nakatani,Tomomi Ide,Tetsuya Amano,Hiroaki Naito,Hironori Nagasaka,Kunihisa Kobayashi,on behalf of,the Japan,TGCV study group, Orphanet Journal of Rare Disease, Vol. 14, No. 1, 2019/05
  • Intractable Coronary Artery Disease in a Type 2 Diabetic Patient Presenting With Triglyceride Deposit Cardiomyovasculopathy, Kozawa J,Higashi M,Shimomura I,Hirano K, Diabetes Care, Vol. 42, No. 5, p. 983-986, 2019/01
  • 摂食,全身代謝と生殖現象 脂質代謝と男性生殖 基礎検討からの提案, 中村 仁美,金 南孝,正木 秀武,熊澤 惠一,平野 賢一,木村 正, 日本生殖医学会雑誌, (一社)日本生殖医学会, Vol. 63, No. 3, p. 255-255, 2018/08
  • Microwave-assisted derivatization of fatty acids for its measurement in milk using high-performance liquid chromatography, Rojeet Shrestha,Yusuke Miura,Ken-Ichi Hirano,Zhen Chen,Hiroaki Okabe,Hitoshi Chiba,Shu-Ping Hui, Analytical Sciences, Japan Society for Analytical Chemistry, Vol. 34, No. 5, p. 575-582, 2018/05
  • Tricaprin Rescues Myocardial Abnormality in a Mouse Model of Triglyceride Deposit Cardiomyovasculopathy., Suzuki A,Yamaguchi S,Li M,Hara Y,Miyauchi H,Ikeda Y,Zhang B,Higashi M,Ikeda Y,Takagi A,Nagasaka H,Kobayashi K,Magata Y,Aoyama T,Hirano K, Journal of Oleo Science, Vol. 67, No. 8, p. 983-989, 2018/04
  • Comparison of neutrophil distribution patterns in Jordans' anomaly among major automated hematology analyzers., Inaba T,Ishizuka K,Suzuki A,Yuasa S,Saito K,Kodama M,Hongo F,Fujita N,Hirano K, International Journal of Laboratory Hematology, Vol. 40, No. 4, p. e78-e81, 2018/03
  • Newly developed selective immunoinactivation assay revealed reduction in adipose triglyceride lipase activity in peripheral leucocytes from patients with idiopathic triglyceride deposit cardiomyovasculopathy, Atsuko Takagi,Yasuyuki Ikeda,Kunihisa Kobayashi,Kazuhiro Kobayashi,Yoshihiko Ikeda,Junji Kozawa,Hideyuki Miyauchi,Ming Li,Chikako Hashimoto,Yasuhiro Hara,Satoshi Yamaguchi,Akira Suzuki,Tatsushi Toda,Hironori Nagasaka,Ken-ichi Hirano, Biochemical and Biophysical Research Communications, Elsevier B.V., Vol. 495, No. 1, p. 646-651, 2018/01/01
  • Treatment with medium chain fatty acids milk of CD36-deficient preschool children., Vol. 50, p. 45-48, 2017/11
  • Change in plasma total, esterified and non-esterified capric acid concentrations during a short-term oral administration of synthetic tricaprin in dogs, Rojeet Shrestha,Ken-Ichi Hirano,Akira Suzuki,Satoshi Yamaguchi,Yusuke Miura,Yi-Fan Chen,Masahiro Mizuta,Hitoshi Chiba,Shu-Ping Hui, Analytical Sciences, Japan Society for Analytical Chemistry, Vol. 33, No. 11, p. 1297-1303, 2017/11
  • Energy Failure Hypothesis for Takotsubo Cardiomyopathy., Hirano K,Shimizu K,Ikeda Y,Shirakami Y,Nagasaka H, Annals of Nuclear Cardiology, Vol. 3, No. 1, p. 105-109, 2017/08
  • Long-chain fatty acid triglyceride (TG) metabolism disorder impairs male fertility: a study using adipose triglyceride lipase deficient mice, Hidetake Masaki,Namhyo Kim,Hitomi Nakamura,Keiichi Kumasawa,Eriko Kamata,Ken-ichi Hirano,Tadashi Kimura, MOLECULAR HUMAN REPRODUCTION, OXFORD UNIV PRESS, Vol. 23, No. 7, p. 452-460, 2017/07
  • Effect of lipid metabolism on male fertility, Namhyo Kim,Hitomi Nakamura,Hidetake Masaki,Keiichi Kumasawa,Ken-ichi Hirano,Tadashi Kimura, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 485, No. 3, p. 686-692, 2017/04
  • Basic utility of Pentra series automated hematology analyzer for screening of Jordans' anomaly, T. Inaba,K. Ishizuka,A. Suzuki,S. Yuasa,K. Saito,M. Kodama,M. Hamada,F. Hongo,N. Fujita,K. -I. Hirano, INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, WILEY-BLACKWELL, Vol. 39, No. 1, p. E1-E3, 2017/02
  • Hepatic aberrant glycosylation by N-acetylglucosaminyltransferase V accelerates HDL assembly, Yoshihiro Kamada,Sachiho Kida,Ken-ichi Hirano,Satoshi Yamaguchi,Akira Suzuki,Chikako Hashimoto,Akihiro Kimura,Motoya Sato,Hironobu Fujii,Tomoaki Sobajima,Akiko Yamamoto,Yusuke Ebisutani,Shinji Takamatsu,Shinichiro Shinzaki,Yuichi Yoshida,Makoto Yamada,Hironori Nagasaka,Tetsuo Takehara,Eiji Miyoshi, AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, AMER PHYSIOLOGICAL SOC, Vol. 311, No. 5, p. G859-G868, 2016/11
  • Synthesis of (2 beta,3 alpha,6-H-2(3))cholesteryl linoleate and cholesteryl oleate as internal standards for mass spectrometry, Yusuke Miura,Shu-Ping Hui,Rojeet Shrestha,Takahisa Hiruma,Seiji Takeda,Hirotoshi Fuda,Shigeo Ikegawa,Ken-ichi Hirano,Hitoshi Chiba, STEROIDS, ELSEVIER SCIENCE INC, Vol. 107, p. 1-9, 2016/03
  • Plasma capric acid concentrations in healthy subjects determined by high-performance liquid chromatography, Rojeet Shrestha,Shu-Ping Hui,Hiromitsu Imai,Satoru Hashimoto,Naoto Uemura,Seiji Takeda,Hirotoshi Fuda,Akira Suzuki,Satoshi Yamaguchi,Ken-ichi Hirano,Hitoshi Chiba, ANNALS OF CLINICAL BIOCHEMISTRY, SAGE PUBLICATIONS INC, Vol. 52, No. 5, p. 588-596, 2015/09
  • Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase, Masahiro Higashi,Ken-ichi Hirano,Kazuhiro Kobayashi,Yoshihiko Ikeda,Ami Issiki,Tetsuo Otsuka,Akira Suzuki,Satoshi Yamaguchi,Nobuhiro Zaima,Seiki Hamada,Hironori Hanada,Chieko Suzuki,Hiroshi Nakamura,Hironori Nagasaka,Toshiyuki Miyata,Yoshihiro Miyamoto,Kunihisa Kobayashi,Hiroaki Naito,Tatsushi Toda, INTERNATIONAL JOURNAL OF CARDIOLOGY, ELSEVIER IRELAND LTD, Vol. 192, p. 30-32, 2015/08
  • Cardiomyocyte steatosis and defective washout of iodine-123-beta-methyl iodophenyl-pentadecanoic acid in genetic deficiency of adipose triglyceride lipase, Ken-ichi Hirano,Yoshihiko Ikeda,Koichiro Sugimura,Yasuhiko Sakata, EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, Vol. 36, No. 9, p. 580-580, 2015/03
  • Refractory hypoglycemia and subsequent cardiogenic shock in starvation and refeeding: Report of three cases, Kentaro Shimizu,Hiroshi Ogura,Masafumi Wasa,Tomoya Hirose,Takeshi Shimazu,Hironori Nagasaka,Ken-ichi Hirano, NUTRITION, ELSEVIER SCIENCE INC, Vol. 30, No. 9, p. 1090-1092, 2014/09
  • Coronary triglyceride deposition in contemporary advanced diabetics, Yoshihiko Ikeda,Nobuhiro Zaima,Ken-ichi Hirano,Masayuki Mano,Kunihisa Kobayashi,Sohsuke Yamada,Satoshi Yamaguchi,Akira Suzuki,Hideaki Kanzaki,Toshimitsu Hamasaki,Jun-ichi Kotani,Seiya Kato,Hironori Nagasaka,Mitsutoshi Setou,Hatsue Ishibashi-Ueda, PATHOLOGY INTERNATIONAL, WILEY-BLACKWELL, Vol. 64, No. 7, p. 325-335, 2014/07
  • A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: A case report and literature review, Kimihiko Kaneko,Hiroshi Kuroda,Rumiko Izumi,Maki Tateyama,Masaaki Kato,Koichiro Sugimura,Yasuhiko Sakata,Yoshihiko Ikeda,Ken-ichi Hirano,Masashi Aoki, NEUROMUSCULAR DISORDERS, PERGAMON-ELSEVIER SCIENCE LTD, Vol. 24, No. 7, p. 634-641, 2014/07
  • Changes of lipoproteins in phenylalanine hydroxylase-deficient children during the first year of life, Hironori Nagasaka,Hirokazu Tsukahara,Yoshiyuki Okano,Ken-ichi Hirano,Toshihiro Sakurai,Shu-Ping Hui,Toshihiro Ohura,Hiromi Usui,Tohru Yorifuji,Satoshi Hirayama,Akira Ohtake,Takashi Miida, CLINICA CHIMICA ACTA, ELSEVIER SCIENCE BV, Vol. 433, p. 1-4, 2014/06
  • Disease-associated marked hyperalphalipoproteinemia, Ken-Ichi Hirano,Hironori Nagasaka,Kazuhiro Kobayashi,Satoshi Yamaguchi,Akira Suzuki,Tatsushi Toda,Manabu Doyu, Molecular Genetics and Metabolism Reports, Elsevier Inc., Vol. 1, No. 1, p. 264-268, 2014/06
  • Peripheral leukocyte anomaly detected with routine automated hematology analyzer sensitive to adipose triglyceride lipase deficiency manifesting neutral lipid storage disease with myopathy/triglyceride deposit cardiomyovasculopathy, Akira Suzuki,Hironori Nagasaka,Yasuhiro Ochi,Kazuhiro Kobayashi,Hiroshi Nakamura,Daisaku Nakatani,Satoshi Yamaguchi,Shinobu Yamaki,Atsushi Wada,Yoshihisa Shirata,Shu-Ping Hui,Tatsushi Toda,Hiroshi Kuroda,Hitoshi Chiba,Ken-Ichi Hirano, Molecular Genetics and Metabolism Reports, Elsevier Inc., Vol. 1, No. 1, p. 249-253, 2014/05
  • Selective evaluation of high density lipoprotein from mouse small intestine by an in situ perfusion technique, Satoshi Yamaguchi,Bo Zhang,Takeshi Tomonaga,Utako Seino,Akiko Kanagawa,Masaru Segawa,Hironori Nagasaka,Akira Suzuki,Takashi Miida,Sohsuke Yamada,Yasuyuki Sasaguri,Takefumi Doi,Keijiro Saku,Mitsuyo Okazaki,Yoshihiro Tochino,Ken-ichi Hirano, JOURNAL OF LIPID RESEARCH, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 55, No. 5, p. 905-918, 2014/05
  • A novel type of human spontaneous coronary atherosclerosis with triglyceride deposition, Yoshihiko Ikeda,Ken-ichi Hirano,Norihide Fukushima,Yoshiki Sawa, EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, Vol. 35, No. 13, p. 875-875, 2014/04
  • Genetic mutations in adipose triglyceride lipase and myocardial up-regulation of peroxisome proliferated activated receptor-gamma in patients with triglyceride deposit cardiomyovasculopathy, Ken-ichi Hirano,Tatsuya Tanaka,Yoshihiko Ikeda,Satoshi Yamaguchi,Nobuhiro Zaima,Kazuhiro Kobayashi,Akira Suzuki,Yasuhiko Sakata,Yasushi Sakata,Kunihisa Kobayashi,Tatsushi Toda,Norihide Fukushima,Hatsue Ishibashi-Ueda,Daniela Tavian,Hironori Nagasaka,Shu-Ping Hui,Hitoshi Chiba,Yoshiki Sawa,Masatsugu Hori, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 443, No. 2, p. 574-579, 2014/01
  • Quantitative proteomic analysis of cultured skin fibroblast cells derived from patients with triglyceride deposit cardiomyovasculopathy, Yasuhiro Hara,Naoko Kawasaki,Ken-Ichi Hirano,Yuuki Hashimoto,Jun Adachi,Shio Watanabe,Takeshi Tomonaga, Orphanet Journal of Rare Diseases, Vol. 8, No. 1, 2013/12/21
  • 生活習慣病の男性生殖能に与える影響 2型糖尿病モデルマウスを用いた検討(The effect of lifestyle related diseases on male fertility: A study using type 2 diabetes model mice), 金 南孝,中村 仁美,正木 秀武,古屋 毅一郎,三宅 達也,熊澤 恵一,筒井 建紀,平野 賢一,木村 正, Reproductive Immunology and Biology, 日本生殖免疫学会, Vol. 28, No. 1-2, p. 90-90, 2013/11
  • Downregulation of adipose triglyceride lipase in the heart aggravates diabetic cardiomyopathy in db/db mice, Tomoaki Inoue,Kunihisa Kobayashi,Toyoshi Inoguchi,Noriyuki Sonoda,Yasutaka Maeda,Eiichi Hirata,Yoshinori Fujimura,Daisuke Miura,Ken-ichi Hirano,Ryoichi Takayanagi, Biochemical and Biophysical Research Communications, Vol. 438, No. 1, p. 224-229, 2013/08/16
  • Vascular smooth muscle cells isolated from adipose triglyceride lipase-deficient mice exhibit distinct phenotype and phenotypic plasticity, Yanhui Lin,Shunmei Chiba,Akira Suzuki,Satoshi Yamaguchi,Takaya Nakanishi,Hirofumi Matsumoto,Yoshihiko Ikeda,Hatsue Ishibashi-Ueda,Ken-Ichi Hirano,Seiya Kato, Biochemical and Biophysical Research Communications, Academic Press Inc., Vol. 434, No. 3, p. 534-540, 2013/05/10
  • Metabolic improvements in intrahepatic porto-systemic venous shunt presenting various metabolic abnormalities by 4-phenylacetate, Hironori Nagasaka,Takashi Miida,Tohru Yorifuji,Ken-ichi Hirano,Ayano Inui,Tomoo Fujisawa,Hirokazu Tsukahara,Hisamitsu Hayashi,Yukihiro Inomata, CLINICA CHIMICA ACTA, ELSEVIER SCIENCE BV, Vol. 419, p. 52-56, 2013/04
  • iPS cell modeling of cardiometabolic diseases, Nakamura K,Hirano K,Wu SM, J Cardiovasc Transl Res, Vol. 6, No. 1, p. 46-53, 2013/02
  • Oxysterol changes along with cholesterol and vitamin D changes in adult phenylketonuric patients diagnosed by newborn mass-screening, Hironori Nagasaka,Yoshiyuki Okano,Akihiko Kimura,Tatsuki Mizuochi,Yoshitami Sanayama,Tomozumi Takatani,Saori Nakagawa,Eri Hasegawa,Ken-ichi Hirano,Hiroshi Mochizuki,Toshihiro Ohura,Mika Ishige-Wada,Hiromi Usui,Tohru Yorifuji,Hirokazu Tsukahara,Satoshi Hirayama,Akira Ohtake,Susumu Yamato,Takashi Miida, CLINICA CHIMICA ACTA, ELSEVIER SCIENCE BV, Vol. 416, p. 54-59, 2013/02
  • Sustained high plasma mannose less sensitive to fluctuating blood glucose in glycogen storage disease type Ia children, Hironori Nagasaka,Tohru Yorifuji,Robert H. J. Bandsma,Tomozumi Takatani,Hisaki Asano,Hiroshi Mochizuki,Mayuko Takuwa,Hirokazu Tsukahara,Ayano Inui,Tomoyuki Tsunoda,Haruki Komatsu,Eitaro Hiejima,Tomoo Fujisawa,Ken-Ichi Hirano,Takashi Miida,Akira Ohtake,Tadao Taguchi,Ichitomo Miwa, Journal of Inherited Metabolic Disease, Vol. 36, No. 1, p. 75-81, 2013/01
  • Reduced Expression of Adipose Triglyceride Lipase Enhances Tumor Necrosis Factor alpha-induced Intercellular Adhesion Molecule-1 Expression in Human Aortic Endothelial Cells via Protein Kinase C-dependent Activation of Nuclear Factor-kappa B, Tomoaki Inoue,Kunihisa Kobayashi,Toyoshi Inoguchi,Noriyuki Sonoda,Masakazu Fujii,Yasutaka Maeda,Yoshinori Fujimura,Daisuke Miura,Ken-ichi Hirano,Ryoichi Takayanagi, JOURNAL OF BIOLOGICAL CHEMISTRY, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 286, No. 37, p. 32045-32053, 2011/09
  • CD36 deficiency predisposing young children to fasting hypoglycemia, Hironori Nagasaka,Tohru Yorifuji,Tomozumi Takatani,Yoshiyuki Okano,Hirokazu Tsukahara,Hidekatsu Yanai,Ken-ichi Hirano,Shu-Ping Hui,Satoshi Hirayama,Tetsuya Ito,Hitoshi Chiba,Takashi Miida, METABOLISM-CLINICAL AND EXPERIMENTAL, W B SAUNDERS CO-ELSEVIER INC, Vol. 60, No. 6, p. 881-887, 2011/06
  • Histamine Deficiency Decreases Atherosclerosis and Inflammatory Response in Apolipoprotein E Knockout Mice Independently of Serum Cholesterol Level, Ke-Yong Wang,Akihide Tanimoto,Xin Guo,Sohsuke Yamada,Shohei Shimajiri,Yoshitaka Murata,Yan Ding,Masato Tsutsui,Seiya Kato,Teruo Watanabe,Hiroshi Ohtsu,Ken-Ichi Hirano,Kimitoshi Kohno,Yasuyuki Sasaguri, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 31, No. 4, p. 800-807, 2011/04
  • Histamine Regulation in Glucose and Lipid Metabolism via Histamine Receptors Model for Nonalcoholic Steatohepatitis in Mice, Ke-Yong Wang,Akihide Tanimoto,Sohsuke Yamada,Xin Guo,Yan Ding,Teruo Watanabe,Takeshi Watanabe,Kimitoshi Kohno,Ken-Ichi Hirano,Hideo Tsukada,Yasuyuki Sasaguri, AMERICAN JOURNAL OF PATHOLOGY, AMER SOC INVESTIGATIVE PATHOLOGY, INC, Vol. 177, No. 2, p. 713-723, 2010/08
  • Altered metabolisms of mediators controlling vascular function and enhanced oxidative stress in asymptomatic children with congenital portosystemic venous shunt, Hironori Nagasaka,Yoshiyuki Okano,Madoka Aizawa,Takashi Miida,Tohru Yorifuji,Go Tajima,Nobuo Sakura,Tomozumi Takatani,Yoshitami Sanayama,Kenji Sugamoto,Mitsufumi Mayumi,Kunihiko Kobayashi,Kenichi Hirano,Masaki Takayanagi,Hirokazu Tsukaharah, METABOLISM-CLINICAL AND EXPERIMENTAL, W B SAUNDERS CO-ELSEVIER INC, Vol. 59, No. 1, p. 107-113, 2010/01
  • A Novel Clinical Entity: Triglyceride Deposit Cardiomyovasculopathy, Ken-ichi Hirano, JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, JAPAN ATHEROSCLEROSIS SOC, Vol. 16, No. 5, p. 702-705, 2009/10
  • Lipoprotein profiles in children with two common cholesteryl ester transfer protein gene mutations, D442G and I14A, during the first year of life, Hironori Nagasaka,Tohru Yorifuji,Toru Momoi,Junko Yorifuji,Kenichi Hirano,Akemi Ota,Tomozumi Takatani,Hirokazu Tsukahara,Masaki Takayanagi,Kunihiko Kobayashi,Hitoshi Chiba,Yukiyasu Sato,Takashi Miida, CLINICA CHIMICA ACTA, ELSEVIER SCIENCE BV, Vol. 406, No. 1-2, p. 52-56, 2009/08
  • Sterol-mediated Regulation of Human Lipin 1 Gene Expression in Hepatoblastoma Cells, Kenji Ishimoto,Hiroki Nakamura,Keisuke Tachibana,Daisuke Yamasaki,Akemi Ota,Ken-ichi Hirano,Toshiya Tanaka,Takao Hamakubo,Juro Sakai,Tatsuhiko Kodama,Takefumi Doi, JOURNAL OF BIOLOGICAL CHEMISTRY, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 284, No. 33, p. 22195-22205, 2009/08
  • Fibrinogen storage disease caused by aguadilla mutation presenting with hypobeta-lipoproteinemia and considerable liver disease, Tsuyoshi Sogo,Hironori Nagasaka,Haruki Komatsu,Ayano Inui,Takashi Miida,Francesco Callea,Paola Francalanci,Ken-Ichi Hirano,Hajime Kitamura,Toru Yorifuji,Tomoo Fujisawa, Journal of Pediatric Gastroenterology and Nutrition, LIPPINCOTT WILLIAMS & WILKINS, Vol. 49, No. 1, p. 133-136, 2009/07
  • Impaired Insulin Secretion in Four Tangier Disease Patients with ABCA1 Mutations, Masahiro Koseki,Akifumi Matsuyama,Kazuhiro Nakatani,Miwako Inagaki,Hajime Nakaoka,Ryota Kawase,Miyako Yuasa-Kawase,Kazumi Tsubakio-Yamamoto,Daisaku Masuda,Jose C. Sandoval,Tohru Ohama,Yumiko Nakagawa-Toyama,Fumihiko Matsuura,Makoto Nishida,Masato Ishigami,Ken-ichi Hirano,Naoki Sakane,Yoshitaka Kumon,Tadashi Suehiro,Tadashi Nakamura,Iichiro Shimomura,Shizuya Yamashita, JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, JAPAN ATHEROSCLEROSIS SOC, Vol. 16, No. 3, p. 292-296, 2009/06
  • Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent period, Hironori Nagasaka,Yoshiyuki Okano,Hirokazu Tsukahara,Yosuke Shigematsu,Toru Momoi,Junko Yorifuji,Takashi Miida,Toshihiro Ohura,Keiko Kobayashi,Takeyori Saheki,Kenichi Hirano,Masaki Takayanagi,Tohru Yorifuji, MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 97, No. 1, p. 21-26, 2009/05
  • Chylomicron remnants are increased in the postprandial state in CD36 deficiency, Daisaku Masuda,Ken-ichi Hirano,Hiroyuki Oku,Jose C. Sandoval,Ryota Kawase,Miyako Yuasa-Kawase,Yasushi Yamashita,Masanori Takada,Kazumi Tsubakio-Yamamoto,Yoshihiro Tochino,Masahiro Koseki,Fumihiko Matsuura,Makoto Nishida,Toshiharu Kawamoto,Masato Ishigami,Masatsugu Hori,Iichiro Shimomura,Shizuya Yamashita, JOURNAL OF LIPID RESEARCH, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 50, No. 5, p. 999-1011, 2009/05
  • Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis, Hironori Nagasaka,Tohru Yorifuji,Kenichi Hirano,Akemi Otac,Yumiko Toyama-Nakagawa,Tomozumi Takatani,Hirokazu Tsukahara,Kunihiko Kobayashi,Masaki Takayanagi,Yukihiro Inomata,Shinji Uemoto,Takashi Miida, METABOLISM-CLINICAL AND EXPERIMENTAL, W B SAUNDERS CO-ELSEVIER INC, Vol. 58, No. 1, p. 48-54, 2009/01
  • Triglyceride Deposit Cardiomyovasculopathy, Ken-ichi Hirano,Yoshihiko Ikeda,Nobuhiro Zaima,Yasuhiko Sakata,Goro Matsumiya, New England Journal of Medicine, Massachusetts Medical Society, Vol. 359, No. 22, p. 2396-2398, 2008/11/27
  • Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome, Hironori Nagasaka,Takashi Miida,Ken-ichi Hirano,Akemi Ota,Kei Murayama,Tohru Yorifuji,Kunihiko Kobayashi,Tornommi Takatani,Hirokazu Tsukahara,Shu-Ping Hui,Masaki Takayanagi,Hitoshi Chiba, ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, Vol. 198, No. 2, p. 434-440, 2008/06
  • Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial Hypercholesterolemia in the first year of life, Hironori Nagasaka,Takashi Miida,Kenichi Hirano,Akemi Ota,Tohru Yorifuji,Tomozumi Takatani,Hirokazu Tsukahara,Masaki Takayanagi,Shu-Ping Hui,Kunihiko Kobayashi,Hitoshi Chiba, JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, ENDOCRINE SOC, Vol. 93, No. 3, p. 779-783, 2008/03
  • Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk, Hironori Nagasaka,Ken-Ichi Hirano,Akira Ohtake,Takashi Miida,Tomozumi Takatani,Kei Murayama,Tohru Yorifuji,Kunihiko Kobayashi,Masaki Kanazawa,Atsushi Ogawa,Masaki Takayanagi, European Journal of Pediatrics, Vol. 166, No. 10, p. 1009-1016, 2007/10
  • Adiponectin deficiency suppresses ApoA-I synthesis in ABCA1 expression and the liver, Hiroyuki Oku,Fumihiko Matsuura,Masahiro Koseki,Jose C. Sandoval,Miyako Yuasa-Kawase,Kazumi Tsubakio-Yamamoto,Daisaku Masuda,Norikazu Maeda,Tohru Ohama,Masato Ishigami,Makoto Nishida,Ken-Ichi Hirano,Shinji Kihara,Masatsugu Hori,Iichiro Shimomura,Shizuya Yamashita, FEBS LETTERS, ELSEVIER SCIENCE BV, Vol. 581, No. 26, p. 5029-5033, 2007/10
  • Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver, Fumihiko Matsuura,Hiroyuki Oku,Masahiro Koseki,Jose C. Sandoval,Miyako Yuasa-Kawase,Kazumi Tsubakio-Yamamoto,Daisaku Masuda,Norikazu Maeda,Ken-ichi Tsujii,Masato Ishigami,Makoto Nishida,Ken-ichi Hirano,Shinji Kihara,Masatsugu Hori,Iichiro Shimomura,Shizuya Yamashita, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 358, No. 4, p. 1091-1095, 2007/07
  • Depletion of high-density lipoprotein and appearance of triglyceride-rich low-density lipoprotein in a Japanese patient with FIC1 deficiency manifesting benign recurrent intrahepatic cholestasis, Hironori Nagasaka,Hitoshi Chiba,Shu-Ping Hui,Hajime Takikawa,Takashi Miida,Masaki Takayanagi,Tohru Yorifuji,Makoto Hasegawa,Akemi Ota,Ken-ichi Hirano,Hideaki Kikuchi,Hirokazu Tsukahara,Kunihiko Kobayashi, JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 45, No. 1, p. 96-105, 2007/07
  • Senescent phenotypes of skin fibroblasts from patients with Tangier disease, Fumihiko Matsuura,Ken-ichi Hirano,Chiaki Ikegami,Jose C. Sandoval,Hiroyuki Oku,Miyako Yuasa-Kawase,Kazumi Tsubakio-Yamamoto,Masahiro Koseki,Daisaku Masuda,Ken-ichi Tsujii,Masato Ishigami,Makoto Nishida,Iichiro Shimomura,Masatsugu Hori,Shizuya Yamashita, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 357, No. 2, p. 493-498, 2007/06
  • Aggregated ursolic acid, a natural triterpenoid, induces IL-1β release from murine peritoneal macrophages: Role of CD36, Yasutaka Ikeda,Akira Murakami,Yoshinori Fujimura,Hirofumi Tachibana,Koji Yamada,Daisaku Masuda,Ken-Ichi Hirano,Shizuya Yamashita,Hajime Ohigashi, Journal of Immunology, Vol. 178, No. 8, p. 4854-4864, 2007/04/15
  • OE-079 HDL-mediated Plaque Stabilization through Enhancement of Cholesterol Efflux and Inhibition of a Novel Proinflammatory Cytokine Proepithelin(Atherosclerosis, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society), Yamashita Shizuya,Matsuyama Akifumi,Koseki Masahiro,Masuda Daisaku,Matsuura Fumihiko,Hirano Kenichi,Hori Masatsugu,Shimomura Iichiro, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 71, No. 0, 2007/03/01
  • Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages, Masahiro Koseki,Ken-ichi Hirano,Daisaku Masuda,Chiaki Ikegami,Masaki Tanaka,Akemi Ota,Jose C. Sandoval,Yumiko Nakagawa-Toyama,Satoshi B. Sato,Toshihide Kobayashi,Yukiko Shimada,Yoshiko Ohno-Iwashita,Fumihiko Matsuura,Iichiro Shimomura,Shizuya Yamashita, JOURNAL OF LIPID RESEARCH, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 48, No. 2, p. 299-306, 2007/02
  • OE-060 Apo B-48 Is a Good Marker for Coronary Risk and Impaired Metabolism of Chylomicron Remnants in Subjects with Metabolic Syndrome(Lipid disorders-1 (H) OE10,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society), Yamashita Shizuya,Sugimoto Taizo,Nishida Makoto,Ishigami Masato,Kirino Motohiro,Masuda Daisaku,Koseki Masahiro,Toyama Yumiko,Matsuyama Akifumi,Hirano Ken-ichi,Hori Masatsugu,Sakai Naohiko,Matsumoto Kengo,Kawamoto Toshiharu,Uchida Yoshiaki, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 70, No. 0, p. 163-163, 2006/03/01
  • Accumulation of chylomicron remnants in diabetic patients in relation to coronary heart disease - Analysis by a novel ELISA for apo B-48, S. Yamashita,T. Sugimoto,K. Tsujii,M. Koseki,M. Nishida,K. Hirano,I. Shimomura,Y. Uchida,N. Sakai, ADVANCES IN HEART DISEASE, MEDIMOND S R L, p. 305-+, 2006
  • Fasting serum apolipoprotein B-48 level measured by novel ELISA is a good marker of postprandial hyperlipidemia and predicts coronary heart disease, S. Yamashita,T. Sugimoto,K. Tsujii,M. Nishida,K. Hirano,I. Shimomura,K. Matsumoto,T. Kawamoto,Y. Masuda,A. Ikeda,T. Okuno,Y. Uchida,N. Sakai, ADVANCES IN HEART DISEASE, MEDIMOND S R L, p. 297-+, 2006
  • Physiological roles of a multi-ligand receptor CD36 in atherogenesis; Insights from human CD36 deficiency, S. Yamashita,D. Masuda,T. Kuwasako,M. Janabi,N. Sakai,I. Shimomura,K. Hirano, ADVANCES IN HEART DISEASE, MEDIMOND S R L, p. 315-+, 2006
  • Cell surface-expressed moesin-like HDL/apoA-I binding protein promotes cholesterol efflux from human macrophages, A Matsuyama,N Sakai,H Hiraoka,K Hirano,S Yamashita, JOURNAL OF LIPID RESEARCH, AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC, Vol. 47, No. 1, p. 78-86, 2006/01
  • Human scavenger receptor class B type I is expressed with cell-specific fashion in both initial and terminal site of reverse cholesterol transport, Y Nakagawa-Toyama,K Hirano,K Tsujii,M Nishida,J Miyagawa,N Sakai,S Yamashita, ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, Vol. 183, No. 1, p. 75-83, 2005/11
  • Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism, Hirano K,Ikegami C,Tsujii K,Zhang Z,Matsuura F,Nakagawa-Toyama Y,Koseki M,Masuda D,Maruyama T,Shimomura I,Ueda Y,Yamashita S, Arterioscler Thromb Vasc Biol, Vol. 25, No. 11, p. 2422-2427, 2005/08
  • Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux, F Matsuura,K Hirano,M Koseki,T Ohama,A Matsuyama,K Tsujii,R Komuro,M Nishida,N Sakai,H Hiraoka,T Nakamura,S Yamashita, METABOLISM-CLINICAL AND EXPERIMENTAL, W B SAUNDERS CO, Vol. 54, No. 8, p. 1095-1101, 2005/08
  • Defective cholesterol efflux in Werner syndrome fibroblasts and its phenotypic correction by Cdc42, a RhoGTPase, ZY Zhang,K Hirano,K Tsukamoto,C Ikegami,M Koseki,K Saijo,T Ohno,N Sakai,H Hiraoka,L Shimomura,S Yamashita, EXPERIMENTAL GERONTOLOGY, PERGAMON-ELSEVIER SCIENCE LTD, Vol. 40, No. 4, p. 286-294, 2005/04
  • Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese, Nagano M,Yamashita S,Hirano K,Takano M,Maruyama T,Ishihara M,Sagehashi Y,Kujiraoka T,Tanaka K,Hattori H,Sakai N,Nakajima N,Egashira T,Matsuzawa Y, J Atheroscler Thromb, Vol. 11, No. 3, p. 110-121, 2004/03
  • Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins, Ishigami M,Yamashita S,Sakai N,Hirano K,Hiraoka H,Nakamura T,Matsuzawa Y, Atherosclerosis, ELSEVIER SCI IRELAND LTD, Vol. 168, No. 2, p. 359-366, 2003/06
  • Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism, T Kuwasako,K Hirano,N Sakai,M Ishigami,H Hiraoka,MJ Yakub,K Yamauchi-Takihara,S Yamashita,Y Matsuzawa, DIABETES CARE, AMER DIABETES ASSOC, Vol. 26, No. 5, p. 1647-1648, 2003/05
  • Vesicular Acidification Is Required for ATP-Binding Cassette Transporter A1-Mediated Cholesterol Efflux, Koseki Masahiro,Matsuyama Akifumi,Sakai Naohiko,Ohama Toru,Nishida Yoshiharu,Hirano Kenichi,Hiraoka Hisatoyo,Nakamura Tadashi,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 67, No. 0, 2003/03/01
  • Measurement of Cholesterol Efflux from Monocyte-Derived Macrophages of Patients with Llpid Disorders and Atherosclerotic Cardiovascular Diseases, Tsujii Kenichi,Hirano Kenichi,Zhang Zhongyan,Matsuura Fumihiko,Ohama Tohru,Kuwasako Takahiro,Koseki Masahiro,Matsuyama Akifumi,Tsukamoto Kosuke,Toyama Yumiko,Tachibana Koichi,Ishigami Masato,Sakai Naohiko,Hiraoka Hisatoyo,Nakamura Tadashi,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 67, No. 0, 2003/03/01
  • A Possible Major Source of Plasma HDL Particles : Role of ATP Binding Cassette A1 (ABCA1) in Human Intestines, Ohama Tohru,Hirano Kenichi,Zhang Zhongyan,Tsujii Kenichi,Toyama Yumiko,Tsukamoto Kosuke,Matsuyama Akifumi,Ishigami Masato,Sakai Naohiko,Hiraoka Hisatoyo,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 67, No. 0, 2003/03/01
  • Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia, T Maruyama,N Sakai,M Ishigami,K Hirano,T Arai,S Okada,E Okuda,A Ohya,N Nakajima,K Kadowaki,E Fushimi,S Yamashita,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 166, No. 1, p. 177-185, 2003/01
  • Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol, Wellington CL,Yang YZ,Zhou S,Clee SM,Tan B,Hirano K,Zwarts K,Kwok A,Gelfer A,Marcil M,Newman S,Roomp K,Singaraja R,Collins J,Zhang LH,Groen AK,Hovingh K,Brownlie A,Tafuri S,Genest J, Jr,Kastelein JJ,Hayden MR, J Lipid Res, Vol. 43, No. 11, p. 1939-1949, 2002/11
  • Retarded intracellular lipid transport associated with reduced expression of Cdc42, a member of Rho-GTPases, in human aged skin fibroblasts - A possible function of Cdc42 in mediating intracellular lipid transport, K Tsukamoto,K Hirano,S Yamashita,N Sakai,C Ikegami,ZY Zhang,F Matsuura,H Hiraoka,A Matsuyama,M Ishigami,Y Matsuzawa, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 22, No. 11, p. 1899-1904, 2002/11
  • Lipid accumulation in smooth muscle cells under LDL loading is independent of LDL receptor pathway and enhanced by hypoxic conditions, Youichiro Wada,Akira Sugiyama,Takashi Yamamoto,Makoto Naito,Noriko Noguchi,Shinji Yokoyama,Maki Tsujita,Yoshiki Kawabe,Mika Kobayashi,Akashi Izumi,Takahide Kohro,Toshiya Tanaka,Hirokazu Taniguchi,Hidenori Koyama,Ken-Ichi Hirano,Shizuya Yamashita,Yuji Matsuzawa,Etsuo Niki,Takao Hamakubo,Tatsuhiko Kodama, Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 22, No. 10, p. 1712-1719, 2002/10/01
  • Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia, Oka T,Yamashita S,Kujiraoka T,Ito M,Nagano M,Sagehashi Y,Egashira T,Nanjee MN,Hirano K,Miller NE,Matsuzawa Y,Hattori H, J Lipid Res, Vol. 43, No. 8, p. 1236-1243, 2002/08
  • Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands, T Ohama,K Hirano,ZY Zhang,R Aoki,K Tsujii,Y Nakagawa-Toyama,K Tsukamoto,C Ikegami,A Matsuyama,M Ishigami,N Sakai,H Hiraoka,K Ueda,S Yamashita,Y Matsuzawa, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 296, No. 3, p. 625-630, 2002/08
  • Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader (R) assay, M Nagano,S Yamashita,K Hirano,M Ito,T Maruyama,M Ishihara,Y Sagehashi,T Oka,T Kujiraoka,H Hattori,N Nakajima,T Egashira,M Kondo,N Sakai,Y Matsuzawa, JOURNAL OF LIPID RESEARCH, LIPID RESEARCH INC, Vol. 43, No. 7, p. 1011-1018, 2002/07
  • Apobec-1 transcription in rat colon cancer: decreased apobec-1 protein production through alterations in polysome distribution and mRNA translation associated with upstream AUGs, Anant S,Mukhopadhyay D,Hirano K,Brasitus TA,Davidson NO, Biochim Biophys Acta, Vol. 1575, No. 1-3, p. 54-62, 2002/05
  • Expression and Functional analyses of Novel Mutations of ATP-binding Cassette Transporter-1 in Japanese Patients with High Density lipoprotein Deficiency, Nishida Yoshiharu,Ohama Tohru,Hirano Kenichi,Tsukamoto Kosuke,Zhang Zhongyan,Matsuyama Akifumi,Tsujii Kenichi,Matsuura Fumihiko,Ishigami Masato,Sakai Naohiko,Hiraoka Hisatoyo,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 66, No. 0, 2002/03/31
  • Premature replicative senescence in skin fibroblasts from Tangier disease, Matsuura Fumihiko,Hirano Kenichi,Tsukamoto Kosuke,Matsuyama Akifumi,Sakai Naohiko,Hiraoka Hisatoyo,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 66, No. 0, 2002/03/31
  • Serum Matrix Metalloproteinases (MMPs) Levels Are Diagnostic Markers of Active Phase in Patients with Takayasu Arteritis, Matsuyama Akifumi,Ishigami Masato,Hiraoka Hisatoyo,Kashine Susumu,Hirata Ayumu,Hirano Kenichi,Sakai Naohiko,Nakamura Tadashi,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 66, No. 0, 2002/03/31
  • Cell-Surface Expressed Moesin-Like HDL/Apo A-I Binding Protein Is Involved in Cholesterol Efflux from Human Monocyte-derived Macrophages, Matsuyama Akifumi,Sakai Naohiko,Sugimoto Taizo,Matsuura Fumihiko,Ishigami Masato,Hirano Kenichi,Hiraoka Hisatoyo,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 66, No. 0, 2002/03/31
  • Expression of Cholesteryl Ester Transfer Protein in Human Atherosclerotic Lesions and Its Implication in Reverse Cholesterol Transport, Zhang Zhongyan,Yamashita Shizuya,Hirano Ken-ichi,Nakagawa-Toyama Yumiko,Matsuyama Akifumi,Nishida Makoto,Ishigami Masato,Sakai Naohiko,Miyagawa Jun-ichiro,Matsuzawa Yuji,Fukasawa Masayoshi,Arai Hiroyuki, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 66, No. 0, 2002/03/31
  • Minocycline Has a Steroid-Sparing Effect in Treatment of Takayasu Arteritis, Matsuyama Akifumi,Ishigami Masato,Hiraoka Hisatoyo,Kashine Susumu,Hirata Ayumu,Hirano Kenichi,Sakai Naohiko,Nakamura Tadashi,Yamashita Shizuya,Matsuzawa Yuji, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 66, No. 0, 2002/03/31
  • Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats, T Sugimoto,S Yamashita,M Ishigami,N Sakai,K Hirano,M Tahara,K Matsumoto,T Nakamura,Y Matsuzawa, JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Vol. 36, No. 2, p. 157-162, 2002/02
  • How a receptor for oxidized low density lipoproteins works in human. Insights from human genetic CD36 deficiency, K Hirano,T Kuwasako,Y Nakagawa-Toyama,T Sugimoto,M Ishigami,N Sakai,H Hiraoka,S Yamashita,Y Matsuzawa, ATHEROSCLEROSIS: RISK FACTORS, DIAGNOSIS, AND TREATMENT, MEDIMOND S R L, p. 127-131, 2002
  • Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency, Y Nishida,K Hirano,K Tsukamoto,M Nagano,C Ikegami,K Roomp,M Ishihara,N Sakane,ZY Zhang,K Tsujii,A Matsuyama,T Ohama,F Matsuura,M Ishigami,N Sakai,H Hiraoka,H Hattori,C Wellington,Y Yoshida,S Misugi,MR Hayden,T Egashira,S Yamashita,Y Matsuzawa, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC ELSEVIER SCIENCE, Vol. 290, No. 2, p. 713-721, 2002/01
  • Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport, ZY Zhang,S Yamashita,K Hirano,Y Nakagawa-Toyama,A Matsuyama,M Nishida,N Sakai,M Fukasawa,H Arai,J Miyagawa,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 159, No. 1, p. 67-75, 2001/11
  • ATP-Binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP, K Tsukamoto,K Hirano,K Tsujii,C Ikegami,Z Zhongyan,Y Nishida,T Ohama,F Matsuura,S Yamashita,Y Matsuzawa, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC, Vol. 287, No. 3, p. 757-765, 2001/09
  • CD36 deficiency and insulin resistance - Reply, K Hirano,T Kuwasako,H Kashiwagi,S Yamashita,Y Matsuzawa, LANCET, LANCET LTD, Vol. 358, No. 9277, p. 244-244, 2001/07
  • Point mutation (-69 G -> A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects, M Nagano,S Yamashita,K Hirano,T Kujiraoka,M Ito,Y Sagehashi,H Hattori,N Nakajima,T Maruyama,N Sakai,T Egashira,Y Matsuzawa, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 21, No. 6, p. 985-990, 2001/06
  • Localization of CD36 and scavenger receptor class A in human coronary arteries - a possible difference in the contribution of both receptors to plaque formation, Y Nakagawa-Toyama,S Yamashita,J Miyagawa,M Nishida,S Nozaki,H Nagaretani,N Sakai,H Hiraoka,K Yamamori,T Yamane,K Hirano,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 156, No. 2, p. 297-305, 2001/06
  • Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen, M Janabi,S Yamashita,K Hirano,K Matsumoto,N Sakai,H Hiraoka,H Kashiwagi,Y Tomiyama,S Nozaki,Y Matsuzawa, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC, Vol. 283, No. 1, p. 26-30, 2001/04
  • CD36 deficiency associated with insulin resistance, K Miyaoka,T Kuwasako,K Hirano,S Nozaki,S Yamashita,Y Matsuzawa, LANCET, LANCET LTD, Vol. 357, No. 9257, p. 686-687, 2001/03
  • Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein, S Yamashita,K Hirano,N Sakai,Y Matsuzawa, BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, ELSEVIER SCIENCE BV, Vol. 1529, No. 1-3, p. 257-275, 2000/12
  • Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux, K Hirano,F Matsuura,K Tsukamoto,ZY Zhang,A Matsuyama,K Takaishi,R Komuro,T Suehiro,S Yamashita,Y Takai,Y Matsuzawa, FEBS LETTERS, ELSEVIER SCIENCE BV, Vol. 484, No. 3, p. 275-279, 2000/11
  • Escherichia coli sepsis increases hepatic apolipoprotein B secretion by inhibiting degradation, Phetteplace HW,Sedkova N,Hirano K,Davidson NO,Lanza-Jacoby SP, Lipids, Vol. 35, No. 10, p. 1079-1085, 2000/10
  • Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects, PN Duchateau,Movsesyan, I,S Yamashita,N Sakai,K Hirano,SA Schoenhaus,PM O'Connor-Kearns,SJ Spencer,RB Jaffe,RF Redberg,BY Ishida,Y Matsuzawa,JP Kane,MJ Malloy, JOURNAL OF LIPID RESEARCH, LIPID RESEARCH INC, Vol. 41, No. 8, p. 1231-1236, 2000/08
  • Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients, M Janabi,S Yamashita,K Hirano,N Sakai,H Hiraoka,K Matsumoto,ZY Zhang,S Nozaki,Y Matsuzawa, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 20, No. 8, p. 1953-1960, 2000/08
  • Identification of a GPI-anchored type HDL-binding protein on human macrophages, Akifumi Matsuyama,Shizuya Yamashita,Naohiko Sakai,Takao Maruyama,Eiko Okuda,Ken-Ichi Hirano,Shinji Kihara,Hisatoyo Hiraoka,Yuji Matsuzawa, Biochemical and Biophysical Research Communications, Academic Press Inc., Vol. 272, No. 3, p. 864-871, 2000/06/16
  • Tangier disease with continuous massive and longitudinal diffuse calcification in the coronary arteries: Demonstration by the sagittal images of intravascular ultrasonography, Ryutaro Komuro,Shizuya Yamashita,Satoru Sumitsuji,Ken-Ichi Hirano,Takao Maruyama,Makoto Nishida,Fumihiko Matsuura,Akifumi Matsuyama,Taizo Sugimoto,Noriyuki Ouchi,Naohiko Sakai,Tadashi Nakamura,Toru Funahashi,Yuji Matsuzawa, Circulation, Lippincott Williams and Wilkins, Vol. 101, No. 20, p. 2446-2448, 2000/05/23
  • Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis, Matsumoto K,Hirano K,Nozaki S,Takamoto A,Nishida M,Nakagawa-Toyama Y,Janabi MY,Ohya T,Yamashita S,Matsuzawa Y, Vol. 20, No. 4, p. 1027-1032, 2000/04
  • Impairment of reverse cholesterol transport system and atherosclerosis, S Yamashita,T Maruyama,K Hirano,N Sakai,N Nakajima,Y Matsuzawa, LIPOPROTEIN METABOLISM AND ATHEROGENESIS, SPRINGER-VERLAG TOKYO, p. 116-123, 2000
  • Expression of CD36 in cultured human aortic smooth muscle cells (HASMCs), K Matsumoto,K Hirano,S Nozaki,M Nishida,T Ohya,MJ Yakub,T Funahashi,S Yamashita,Y Matsuzawa, LIPOPROTEIN METABOLISM AND ATHEROGENESIS, SPRINGER-VERLAG TOKYO, p. 272-274, 2000
  • Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions, K Hirano,S Yamashita,Y Nakagawa,T Ohya,F Matsuura,K Tsukamoto,Y Okamoto,A Matsuyama,K Matsumoto,J Miyagawa,Y Matsuzawa, CIRCULATION RESEARCH, LIPPINCOTT WILLIAMS & WILKINS, Vol. 85, No. 1, p. 108-116, 1999/07
  • Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia - a possible pathogenesis of necrobiotic xanthogranuloma, F Matsuura,S Yamashita,K Hirano,M Ishigami,H Hiraoka,R Tamura,T Nakagawa,M Nishida,N Sakai,T Nakamura,S Nozaki,T Funahashi,C Matsumoto,M Higashiyama,K Yoshikawa,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 142, No. 2, p. 355-365, 1999/02
  • An alternatively spliced form of apobec-1 messenger RNA is overexpressed in human colon cancer, Lee RM,Hirano K,Anant S,Baunoch D,Davidson NO, Gastroenterology, Vol. 115, No. 5, p. 1096-1103, 1998/11
  • A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet, Powell-Braxton L,Veniant M,Latvala RD,Hirano K,Won WB,Ross J,Dybdal N,Zlot CH,Young SG,Davidson NO, Nat Med, Vol. 4, No. 8, p. 934-938, 1998/08
  • Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes, von Wronski MA,Hirano K,Cagen LM,Wilcox HG,Raghow R,Thorngate FE,Heimberg M,Davidson NO,Elam MB, Metabolism, Vol. 47, No. 7, p. 869-873, 1998/07
  • Cholesteryl ester transfer protein deficiency: virtue or vice?, Y Matsuzawa,S Yamashita,N Sakai,K Hirano,T Maruyama, ATHEROSCLEROSIS XI, ELSEVIER SCIENCE BV, Vol. 1155, p. 135-139, 1998
  • Troglitazone action is independent of adipose tissue, Burant CF,Sreenan S,Hirano K,Tai TA,Lohmiller J,Lukens J,Davidson NO,Ross S,Graves RA, J Clin Invest, Vol. 100, No. 11, p. 2900-2908, 1997/12
  • Cloning and characterization of the rat apobec-1 gene: a comparative analysis of gene structure and promoter usage in rat and mouse, Hirano K,Min J,Funahashi T,Davidson NO, J Lipid Res, Vol. 38, No. 6, p. 1103-1119, 1997/06
  • Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan - Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity, K Hirano,S Yamashita,N Nakajima,T Arai,T Maruyama,Y Yoshida,M Ishigami,N Sakai,K KamedaTakemura,Y Matsuzawa, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, AMER HEART ASSOC, Vol. 17, No. 6, p. 1053-1059, 1997/06
  • Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C, E Shinohara,S Yamashita,S Kihara,K Hirano,M Ishigami,T Arai,S Nozaki,K KamedaTakemura,S Kawata,Y Matsuzawa, HEPATOLOGY, W B SAUNDERS CO, Vol. 25, No. 6, p. 1502-1506, 1997/06
  • Characterization of the human apobec-1 gene: expression in gastrointestinal tissues determined by alternative splicing with production of a novel truncated peptide, Hirano K,Min J,Funahashi T,Baunoch DA,Davidson NO, J Lipid Res, Vol. 38, No. 5, p. 847-859, 1997/05
  • Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E-Suita), K Yanagi,S Yamashita,H Hiraoka,M Ishigami,S Kihara,K Hirano,N Sakai,S Nozaki,T Funahashi,K KamedaTakemura,M Kubo,K Tokunaga,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER IRELAND LTD, Vol. 131, No. 1, p. 49-58, 1997/05
  • High-density lipoproteins from probucol-treated patients have increased capacity to promote cholesterol efflux from mouse peritoneal macrophages loaded with acetylated low-density lipoproteins, Ishigami M,Yamashita S,Sakai N,Hirano K,Arai T,Maruyama T,Takami S,Koyama M,Kameda-Takemura K,Matsuzawa Y, Eur J Clin Invest, Vol. 27, No. 4, p. 285-292, 1997/04
  • Molecular genetics of plasma cholesteryl ester transfer protein, Shizuya Yamashita,Naohiko Sakai,Ken-Ichi Hirano,Takeshi Arai,Masato Ishigami,Takao Maruyama,Yuji Matsuzawa, Current Opinion in Lipidology, Vol. 8, No. 2, p. 101-110, 1997/04
  • A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects, Takeshi Arai,Shizuya Yamashita,Naohiko Sakai,Ken-Ichi Hirano,Sugako Okada,Masato Ishigami,Takao Maruyama,Mitsukazu Yamane,Hitoshi Kobayashi,Shuichi Nozaki,Tohru Funahashi,Kaoru Kameda-Takemura,Norimichi Nakajima,Yuji Matsuzawa, Journal of Lipid Research, Vol. 37, No. 10, p. 2145-2154, 1996/10
  • Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48, Hirano K,Young SG,Farese RV, Jr,Ng J,Sande E,Warburton C,Powell-Braxton LM,Davidson NO, Vol. 271, No. 17, p. 9887-9890, 1996/04
  • ATHEROSCLEROTIC DISEASE IN MARKED HYPERALPHALIPOPROTEINEMIA - COMBINED REDUCTION OF CHOLESTERYL ESTER TRANSFER PROTEIN AND HEPATIC TRIGLYCERIDE LIPASE, K HIRANO,S YAMASHITA,Y KUGA,N SAKAI,S NOZAKI,S KIHARA,T ARAI,K YANAGI,S TAKAMI,M MENJU,M ISHIGAMI,Y YOSHIDA,K KAMEDATAKEMURA,K HAYASHI,Y MATSUZAWA, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, AMER HEART ASSOC, Vol. 15, No. 11, p. 1849-1856, 1995/11
  • Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency, Sakai N,Yamashita S,Hirano K,Ishigami M,Arai T,Kobayashi K,Funahashi T,Matsuzawa Y, Eur J Clin Invest, Vol. 25, No. 5, p. 332-339, 1995/05
  • FREQUENCY OF EXON-15 MISSENSE MUTATION (442D-G) IN CHOLESTERYL ESTER TRANSFER PROTEIN GENE IN HYPERALPHALIPOPROTEINEMIC JAPANESE SUBJECTS, N SAKAI,S YAMASHITA,K HIRANO,M MENJU,T ARAI,K KOBAYASHI,M ISHIGAMI,Y YOSHIDA,T HOSHINO,N NAKAJIMA,K KAMEDATAKEMURA,Y MATSUZAWA, ATHEROSCLEROSIS, ELSEVIER SCI PUBL IRELAND LTD, Vol. 114, No. 2, p. 139-145, 1995/04
  • Very high density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function, Yamashita S,Ishigami M,Arai T,Sakai N,Hirano K,Kameda-Takemura K,Tokunaga K,Matsuzawa Y, Ann N Y Acad Sci, Vol. 748, p. 606-608, 1995/01
  • CHOLESTEROL ESTER TRANSFER PROTEIN AND CARDIOVASCULAR DISEASE, Y MATSUZAWA,S YAMASHITA,N SAKAI,K HIRANO,M ISHIGAMI, ATHEROSCLEROSIS X, ELSEVIER SCIENCE PUBL B V, Vol. 1066, p. 736-742, 1995
  • Molecular defect and atherogenicity in cholesteryl ester transfer protein deficiency, K. I. Hirano,S. Yamashita,N. Sakai,T. Arai,Y. Yoshida,S. Nozaki,K. Kameda-Takemura,Y. Matsuzawa, Annals of the New York Academy of Sciences, Blackwell Publishing Inc., Vol. 748, p. 599-602, 1995/01
  • LARGE AND CHOLESTERYL ESTER-RICH HIGH-DENSITY-LIPOPROTEINS IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) DEFICIENCY CAN NOT PROTECT MACROPHAGES FROM CHOLESTEROL ACCUMULATION INDUCED BY ACETYLATED LOW-DENSITY LIPOPROTEINS, M ISHIGAMI,S YAMASHITA,N SAKAI,T ARAI,K HIRANO,H HIRAOKA,K KAMEDATAKEMURA,Y MATSUZAWA, JOURNAL OF BIOCHEMISTRY, JAPANESE BIOCHEMICAL SOC, Vol. 116, No. 2, p. 257-262, 1994/08
  • Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity, Arai T,Yamashita S,Hirano K,Sakai N,Kotani K,Fujioka S,Nozaki S,Keno Y,Yamane M,Shinohara E, Arterioscler Thromb, Vol. 14, No. 7, p. 1129-1136, 1994/07
  • A MISSENSE MUTATION IN THE CHOLESTERYL ESTER TRANSFER PROTEIN GENE WITH POSSIBLE DOMINANT EFFECTS ON PLASMA HIGH-DENSITY-LIPOPROTEINS, K TAKAHASHI,XC JIANG,N SAKAI,S YAMASHITA,K HIRANO,H BUJO,H YAMAZAKI,J KUSUNOKI,T MIURA,P KUSSIE,Y MATSUZAWA,Y SAITO,A TALL, JOURNAL OF CLINICAL INVESTIGATION, ROCKEFELLER UNIV PRESS, Vol. 92, No. 4, p. 2060-2064, 1993/10
  • DECREASE OF HEPATIC TRIGLYCERIDE LIPASE LEVELS AND INCREASE OF CHOLESTERYL ESTER TRANSFER PROTEIN-LEVELS IN PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS - RELATIONSHIP TO ABNORMALITIES IN HIGH-DENSITY-LIPOPROTEIN, H HIRAOKA,S YAMASHITA,Y MATSUZAWA,M KUBO,S NOZAKI,N SAKAI,K HIRANO,S KAWATA,S TARUI, HEPATOLOGY, W B SAUNDERS CO, Vol. 18, No. 1, p. 103-110, 1993/07
  • FREQUENCY OF INTRON-14 SPLICING DEFECT OF CHOLESTERYL ESTER TRANSFER PROTEIN GENE IN THE JAPANESE GENERAL-POPULATION - RELATION BETWEEN THE MUTATION AND HYPERALPHALIPOPROTEINEMIA, K HIRANO,S YAMASHITA,T FUNAHASHI,N SAKAI,M MENJU,M ISHIGAMI,H HIRAOKA,K KAMEDATAKEMURA,K TOKUNAGA,T HOSHINO,K KUMASAKA,K KAWANO,Y MATSUZAWA, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 100, No. 1, p. 85-90, 1993/04
  • POLYDISPERSE LOW-DENSITY LIPOPROTEINS IN HYPERALPHALIPOPROTEINEMIC CHRONIC ALCOHOL DRINKERS IN ASSOCIATION WITH MARKED REDUCTION OF CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY, K HIRANO,Y MATSUZAWA,N SAKAI,H HIRAOKA,S NOZAKI,T FUNAHASHI,S YAMASHITA,M KUBO,S TARUI, METABOLISM-CLINICAL AND EXPERIMENTAL, W B SAUNDERS CO, Vol. 41, No. 12, p. 1313-1318, 1992/12
  • Low-density lipoproteins in hyperalphalipoproteinemic heavy alcohol drinkers have reduced affinity for the low-density lipoprotein receptor, Ken-ichi Hirano,Shizuya Yamashita,Naohiko Sakai,Hisatoyo Hiraoka,Yuhya Ueyama,Tohru Funahashi,Yuji Matsuzawa, Clinical Biochemistry, Vol. 25, No. 5, p. 357-362, 1992/10
  • EFFECTS OF PURIFIED EICOSAPENTAENOIC ACID ETHYL-ESTER ON PLASMA-LIPOPROTEINS IN PRIMARY HYPERCHOLESTEROLEMIA, S NOZAKI,Y MATSUZAWA,K HIRANO,N SAKAI,M KUBO,S TARUI, INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, VERLAG HANS HUBER, Vol. 62, No. 3, p. 256-260, 1992
  • Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency, Naohiko Sakai,Yuji Matsuzawa,Ken-Ichi Hirano,Shizuya Yamashita,Shuichi Nozaki,Yuhya Ueyama,Masaharu Kubo,Seiichiro Tarui, Arteriosclerosis, Thrombosis, and Vascular Biology, Lippincott Williams and Wilkins, Vol. 11, No. 1, p. 71-79, 1991/02
  • Studies on the two families of hyperalphalipoproteinemia caused by complete deficiency of cholesteryl ester transfer activity - Existence of small polydisperse LDL and markedly large HDL, S. Yamashita,Y. Ueyama,S. Kihara,T. Kawamoto,T. Nakamura,M. Kubo,Y. Matsuzawa,S. Tarui,H. Kako,G. Mizuno,T. Yasugi,H. Akioka,K. Hirano,M. Okazaki, Journal of Japan Atherosclerosis Society, Vol. 17, No. 2, p. 371-379, 1989

Misc.

  • 血管内の中性脂肪代謝異常と血管疾患との関わりを考える 中性脂肪と血管, 財満信宏,平野賢一, 化学と生物, Vol. 60, No. 12, p. 627-629, 2022/12
  • 高HDL-コレステロール血症:診療のポイント, Ken-ichi Hirano, Vol. 5146, p. 34-39, 2022/12
  • ー, Coronary Intervention, Vol. 17, No. 5, p. 10-16, 2021/09
  • 原発性中性脂肪蓄積心筋血管症, 平野賢一, 医学のあゆみ, Vol. 277, No. 5, p. 418-425, 2021/05
  • 中性脂肪蓄積心筋血管症, 東 将浩,平野賢一, 画像診断, Vol. 41, No. 5, p. 428-429, 2021/03
  • 中性脂肪蓄積心筋血管症の診断に役立つ臨床的因子の検討, 星 佳佑,宮内 秀行,平野 賢一,小林 欣夫, 月刊 心臓, Vol. 52, No. 12, p. 29-35, 2020/12
  • Refeeding syndrome associated with hypoglycemia in patients with severe malnutrition, Kentaro Shimizu,Hiroshi Ogura,Hiroki Takahashi,Masafumi Wasa,Ken-ichi Hirano, JSPEN, Vol. 2, No. 2, p. 95-102, 2020/05
  • 糖尿病と虚血性心疾患, 橋本千佳子,平野賢一, 月刊 糖尿病ライフ さかえ, Vol. 59, No. 9, p. 5-10, 2019/09
  • Triglyceride Deposit Cardiomyovasculopathy, Hirano K,Li M,Ikeda Y, Human Pathobiochemistry, p. 111-119, 2019/01
  • TG蓄積心筋血管症(TGCV)-TGCV重症度スコアの開発-, 橋本千佳子,平野賢一, 最新医学別冊 診断と治療のABC 高TG血症, 最新医学社, Vol. 138, 2018/09
  • Diagnostic Criteria and Severity Score for Triglyceride Deposit Cardiomyovasculopathy, Miyauchi H,Hashimoto C,Ikeda Y,Li M,Nakano Y,Kozawa J,Sai E,Nagasawa Y,Sugimura K,Kinugawa S,Kawaguchi K,Shimada K,Ide T,Amano T,Higashi M,Inaba T,Nakamura H,Kobayashi K,Hirano K, Annals of Nuclear Cardiology, Vol. 4, No. 1, p. 94-100, 2018/08
  • 中鎖脂肪酸による疾患の制御, 原 康洋,平野 賢一, 実験医学増刊号「脂質クオリティ」, 株式会社 羊土社, Vol. 36, No. 10, p. 147-152, 2018/06
  • 中性脂肪蓄積心筋血管症(TGCV)を合併した2型糖尿病の3症例, 小澤 純二,平野 賢一,岩橋 博見,下村 伊一郎, 糖尿病, (一社)日本糖尿病学会, Vol. 61, No. Suppl.1, p. S-252, 2018/04
  • 中鎖脂肪酸は遺伝的Adipose triglyceride lipase欠損症患者の栄養療法として有用か, 安井洋子,安井洋子,鈴木朗,平野賢一,竹中優, 日本栄養・食糧学会近畿支部大会および公開シンポジウム講演抄録集, Vol. 56th, 2017/11/01
  • 中性脂肪蓄積心筋血管症‐この難病を1日でも早く克服する‐, 平野 賢一, 日本内科学会誌, 日本内科学会, Vol. 106, p. 2385-2390, 2017/11
  • 中性脂肪蓄積心筋血管症(TGCV)における末梢血多形核白血球の空胞に関する検討, 鈴木朗,二日市良彰,稲葉亨,小澤純二,江副幸子,山口知是,平野賢一, 臨床病理, Vol. 65, No. 補冊, p. 250-250, 2017/10/20
  • 血漿カプリン酸を定量するための改良LC/MS検定法(An improved LC/MS assay for the measurement of plasma capric acid), 冨田 優理,Shrestha Rojeet,平野 賢一,千葉 仁志,惠 淑萍, 臨床化学, (一社)日本臨床化学会, Vol. 46, No. Suppl.1, p. 285-285, 2017/09
  • 自動血球計数器Pentra MS CRPによるJordan異常検出に関する検討, 稲葉亨,湯浅宗一,齊藤憲祐,児玉真衣,石塚勝敏,濱田基明,藤田直久,鈴木朗,二日市良彰,平野賢一, 日本臨床検査自動化学会会誌, Vol. 42, No. 4, 2017/08/15
  • Imaging Modalities for Triglyceride deposit cardiomyovasculopathy, Higashi M,Ikeda Y,Miyauchi H,Zaima N,Suzuki A,Li M,Kobayashi K,Naito H,Hirano K, Annals of Nuclear Cardiology, Vol. 3, No. 1, p. 94-102, 2017/08
  • 中性脂肪蓄積心筋血管症(TGCV)における末梢血多核白血球の空胞に関する検討, 鈴木朗,二日市良彰,小澤純二,稲葉亨,江副幸子,山口知是,平野賢一, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 49th, 2017/06/25
  • 中性脂肪蓄積心筋血管症(Triglyceride deposit cardiomyovasculopathy:TGCV)における末梢血顆粒球の空胞について―患者の早期発見のために―, 鈴木朗,稲葉亨,二日市良彰,平野賢一, 臨床病理, Vol. 65, No. 6, 2017/06/25
  • ヒト小腸由来高比重リポ蛋白(Small intestine‐derived HDL,SI‐HDL)の選択的・簡易測定法の開発―アポリポ蛋白AIVをマーカーとして―, 平野賢一,宮下かずや,恩田弘明,山口知是,高藤和輝,橋本千佳子,李銘,鈴木朗,原康洋,足立淳,朝長毅,張波,長坂博範,前田和久,梶波康二, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 49th, p. 229 (WEB ONLY)-229, 2017/06/25
  • 中性脂肪蓄積心筋血管症(TGCV)患者線維芽細胞を用いた細胞内Triglyceride蓄積機構の解析, 原康洋,平野賢一,山口知是,鈴木朗,高木敦子,池田康行,恩田弘明,川崎直子,足立淳,朝長毅, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 49th, p. 298 (WEB ONLY)-298, 2017/06/25
  • 原発性中性脂肪蓄積心筋血管症の原因酵素,Adipose triglyceride lipase(ATGL)活性測定系の開発, 高木敦子,池田康行,小林邦久,鈴木朗,橋本千佳子,平野賢一, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 49th, 2017/06/25
  • 中鎖脂肪酸療法により心不全症状が改善したCD36欠損症の一例, 平野賢一,長井直子,橋本千佳子,鈴木朗,山口知是,李銘,原康洋,柏木浩和,冨山佳昭,長坂博範, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 49th, p. 297 (WEB ONLY)-297, 2017/06/25
  • 小腸由来高比重リポ蛋白Small Intestine‐derived HDL(SI‐HDL)―新規創薬ターゲットとしての可能性―, 平野賢一,山口知是,辻田麻紀,鈴木朗,恩田弘明,原康洋,朝長毅,槇島誠, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 49th, 2017/06/25
  • Plasma capric acid concentrations during a short-term oral administration of mediumchain triglycerides, SHRESTHA Rojeet,HIRANO Kenichi,SUZUKI Akira,YAMAGUCHI Satoshi,CHIBA Hitoshi,HUI Shu‐Ping, 日本動脈硬化学会総会・学術集会プログラム・抄録集(Web), Vol. 49th, 2017/06/25
  • 中鎖脂肪酸療法により難治性狭心症が改善した特発性中性脂肪蓄積心筋血管症の一例, 平野 賢一,安井 洋子,東 将浩,坂口 学,鈴木 朗,高木 敦子,Shrestha Rojeet,橋本 千佳子,李 銘,原 康洋,山口 知是,池田 康行,惠 淑萍,内藤 博昭,長坂 博範, 日本動脈硬化学会総会プログラム・抄録集, (一社)日本動脈硬化学会, Vol. 49回, p. 241-241, 2017/06
  • 中鎖脂肪酸療法が著効を示した特発性中性脂肪蓄積心筋血管症の一例, 橋本 千佳子,鈴木 朗,高木 敦子,シュレスタ・ロジート,中林 十士紀,李 銘,池田 康行,惠 淑萍,和田 晃,平野 賢一, 日本動脈硬化学会総会プログラム・抄録集, (一社)日本動脈硬化学会, Vol. 49回, p. 297-297, 2017/06
  • 極希少疾患,遺伝的Adipose triglyceride lipase欠損症患者における中鎖脂肪酸を用いた栄養療法の有用性について, 安井洋子,安井洋子,鈴木朗,平野賢一,竹中優, 日本栄養・食糧学会大会講演要旨集, Vol. 71st, 2017/04/28
  • 中性脂肪蓄積心筋血管症(TGCV), 平野 賢一, 診断モダリティとしての心筋病理, p. 146-147, 2017
  • 中性脂肪蓄積心筋血管症 この難病を1日でも早く克服する, 平野 賢一, 臨床評価, Vol. 43, No. 2, p. 456-459, 2016
  • 心臓血管における脂肪毒性 ―中性脂肪蓄積心筋血管症(triglyceride deposit cardiomyovasculopathy;TGCV)の病態から―, 平野 賢一, The Lipid, Vol. 27, No. 3, p. 79-85, 2016
  • 中鎖脂肪酸とは, 平野 賢一,青山,敏明, そうだったんだ!脂質異常症, p. 8-9, 2016
  • 中性脂肪蓄積心筋血管症, 平野 賢一, CARDIAC PRACTICE, Vol. 27, No. 4, p. 285-289, 2016
  • 多項目自動血球分析装置XNシリーズによる,原発性中性脂肪蓄積心筋血管症由来の好中球脂肪滴の検出, 和田淳,鈴木朗,鈴木朗,山本志緒里,海道雅子,越智康浩,惠淑萍,千葉仁志,平野賢一,平野賢一, 臨床病理, Vol. 63, 2015/10/20
  • ATGL欠損SMCsの遊走能亢進は,動脈内膜肥厚を進展させる, 野口紘嗣,山田壮亮,名和田彩,WAN Katuyou,山口知是,中山敏幸,笹栗靖之,平野賢一, 日本病理学会会誌, (一社)日本病理学会, Vol. 104, No. 1, p. 499-499, 2015/03/23
  • 診断の手引き:中性脂肪蓄積心筋血管症(初版), 班長,平野賢一, 難治性疾患実用化研究事業, 2015/03
  • 脂質異常症による動脈硬化の病理, 池田善彦,平野賢一, 最新医学別冊 診断と治療のABC 101高LDL-C血症・低HDL-C血症 2015;別冊, Vol. 101, p. 30-40, 2015
  • 機能性脂肪酸に関する分析, 惠 淑萍,Shrestha Rojeet,平野 賢一,鈴木 朗,千葉 仁志, 日本未病システム学会学術総会抄録集, (一社)日本未病システム学会, Vol. 21回, p. 121-121, 2014/10
  • 中性脂肪蓄積心筋血管症におけるJordans' anomalyを自動血球分析装置で検出する, 鈴木 朗,和田 淳,長坂 博範,越智 康浩,千葉 仁志,惠 淑萍,平野 賢一, 臨床病理, 日本臨床検査医学会, Vol. 62, No. 補冊, p. 126-126, 2014/10
  • 他項目自動血球分析装置XE-5000 WBC/BASOチャンネルによる、中性脂肪蓄積心筋血管症判別原理の検証, 和田 淳,鈴木 朗,山本 志緒里,越智 康浩,惠 淑萍,千葉 仁志,平野 賢一, 臨床病理, 日本臨床検査医学会, Vol. 62, No. 補冊, p. 127-127, 2014/10
  • 中鎖脂肪酸のHPLC法による定量分析, 惠 淑萍,しゅれすた・ろじーと,平野 賢一,鈴木 朗,千葉 仁志, 臨床病理, 日本臨床検査医学会, Vol. 62, No. 補冊, p. 299-299, 2014/10
  • LC/MSによる誘導体化脂肪酸の分析, 惠 淑萍,ロジート・シュレスタ,平野 賢一,鈴木 朗,千葉 仁志, JSBMS Letters, (一社)日本医用マススペクトル学会, Vol. 39, No. Suppl., p. 52-52, 2014/09
  • ATGL欠損による脂質代謝異常は,血管障害による内膜肥厚を促進させ得る, 野口紘嗣,山田壮亮,鍋島篤典,北田昇平,王克よう,山口知是,笹栗靖之,平野賢一, 日本病理学会会誌, (一社)日本病理学会, Vol. 103, No. 1, p. 255-255, 2014/03/26
  • Quantitative proteomic analysis of cardiac muscles derived from Adipose triglyceride lipase knockout mice, Hara Yasuhiro,Sano Shozo,Hashimoto Yuuki,Kawasaki Naoko,Hirano Ken-ichi,Suzuki Akira,Yamaguchi Satoshi,Tomonaga Takeshi, Abstracts for Annual Meeting of Japanese Proteomics Society, Japanese Proteomics Society (Japan Human Proteome Organisation), Vol. 2014, No. 0, p. 89-89, 2014
  • TGCVの皮膚線維芽細胞におけるトリグリセリドのLC/MSによる分析, 惠 淑萍,平野 賢一,Shrestha Rojeet,千葉 仁志, JSBMS Letters, (一社)日本医用マススペクトル学会, Vol. 38, No. Suppl., p. 70-70, 2013/08
  • 中鎖脂肪酸を代謝するAdipose triglyceride lipase(ATGL)の造精能における機能, 正木 秀武,中村 仁美,平野 賢一,熊澤 恵一,瀧内 剛,藤森 由香,後安 聡子,金 南孝,三宅 達也,古谷 毅一郎,筒井 建紀,木村 正, 日本生殖医学会雑誌, (一社)日本生殖医学会, Vol. 58, No. 1-2, p. 70-71, 2013/04
  • FIC1欠損症, 長坂博範,平野賢一, 先天代謝異常ハンドブック, p. 396-397, 2013
  • ATGL欠損症, 平野賢一,鈴木 朗, 先天代謝異常ハンドブック, p. 394-395, 2013
  • Ectopic Wild Type Gene Transfer Successfully Corrects Vascular Smooth Muscle Phenotypes of Adipose Tissue Triglyceride Lipase Deficient Mouse, Yanhui Lin,Shunmei Chiba,Akira Suzuki,Satoshi Yamaguchi,Takaya Nakanishi,Hirofumi Matsumoto,Yoshihiko Ikeda,Hatsue Ishibashi-Ueda,Ken-ichi Hirano,Seiya Kato, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 126, No. 21, 2012/11
  • 褐色脂肪細胞と白色脂肪細胞【応用編】中性脂肪蓄積心筋血管症, 平野賢一,鈴木朗, 医学のあゆみ, Vol. 242, No. 12, p. 937-941, 2012/09/22
  • Adipose triglyceride lipase(ATGL)欠損マウスにおける生殖能の検討, 正木秀武,中村仁美,熊澤恵一,香山晋輔,筒井建紀,鈴木朗,山口知是,平野賢一,木村正, 日本生殖医学会雑誌, Vol. 57, No. 3, p. 121-121, 2012/07
  • 脂質異常症と脂質蓄積症, 平野賢一,長坂博範, Surgery Frontier, Vol. 19, p. 23-28, 2012
  • 中性脂肪蓄積心筋血管症, 平野 賢一, 循環器内科, Vol. 71, p. 576-580, 2012
  • 中性脂肪蓄積心筋血管症, 平野 賢一, 先端医療シリーズ43 循環器疾患の最新医療, p. 114-117, 2012
  • Triglyceride Deposit Cardiomyovasculopathy. A Novel Clinical Entity Found Out Cardiac Translant Recipients in Our Country, Ken-Ichi Hirano, JOURNAL OF CARDIAC FAILURE, CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS, Vol. 17, No. 9, p. S136-S136, 2011/09
  • 中性脂肪蓄積心筋血管症(triglyceride deposit cardiomyovasculopathy;TGCV), 平野 賢一, The Lipid, Vol. 22, No. 2, p. 210-213, 2011/04
  • 中性脂肪蓄積心筋血管症, 平野 賢一, 病理と臨床, Vol. 29, No. 3, p. 254-256, 2011
  • 中性脂肪蓄積心筋血管症, 平野 賢一, カレントテラピー, Vol. 29, 2011
  • 中性脂肪蓄積心筋血管症, 平野 賢一, 呼吸と循環, Vol. 59, p. 1115-1119, 2011
  • 動脈硬化を診る―リスク評価と病態の検査―1 脂質・リポ蛋白の検査 b)リポ蛋白の調節因子 1)コレステリルエステル転送蛋白(CETP)・リン脂質転送蛋白(PLTP), 平野賢一,鈴木朗, Med Technol, Vol. 38, No. 13, p. 1356-1360, 2010/12/20
  • ATGL(adipose triglyceride lipase)遺伝子変異によるNeutral lipid storage disease with myopathyの二例, 棚橋 貴夫,隅 寿恵,岡崎 周平,平岡 宏太良,長野 清一,高橋 正紀,佐古田 三郎,依藤 史郎,平野 賢一,藤村 晴俊, 臨床神経学, (一社)日本神経学会, Vol. 50, No. 10, p. 763-763, 2010/10
  • HDL治療の現況と問題点, 平野 賢一, Medical Practice, Vol. 27, No. 3, p. 509-513, 2010
  • 中性脂肪蓄積心筋血管症, 総合臨床, Vol. Vol.59, No.8, 1729-1732, 2010
  • Triglyceride deposit cardiomyovasculopathy,TGCV, Sogo rinsho, Vol. Vol.59, No.8, 1729-1732, 2010
  • ヒト肝癌由来細胞におけるヒトLipin 1遺伝子の発現制御機構, 石本憲司,中村太樹,橘敬祐,山崎大典,大田明生,平野賢一,田中十志也,浜窪隆雄,酒井寿郎,児玉龍彦,土井健史, 日本分子生物学会年会講演要旨集, Vol. 32nd, No. Vol.4, 2009
  • Sigmoid septumによる左室流出路狭窄に対しPTSMAが著効した一例, 北庄司絵美,塚本泰正,朝野仁裕,坂田泰史,平野賢一,山下静也,大津欣也,南都伸介, 日本循環器学会近畿地方会(Web), Vol. 107th, 2009
  • EZETIMIBE MARKEDLY REDUCED SERUM PLANT STEROLS IN JAPANESE PATIENTS WITH SITOSTEROLEMIA, M. Koseki,K. Tsubakio-Yamamoto,M. Yuasa-Kawase,H. Oku,J. C. Sandoval,D. Masuda,F. Matsuura,M. Nishida,M. Ishigami,K. Hirano,H. Hattori,I. Shimomura,M. Hori,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 9, No. 1, p. 185-185, 2008/05
  • CHYLOMICRON REMNANTS ARE INCREASED IN CD36 DEFICIENCY AT POSTPRANDIAL STATE, D. Masuda,K. Hirano,H. Oku,J. Sandoval,M. Kawase,K. Yamamoto,M. Koseki,F. Matsuura,Y. Tochino,R. Kawase,M. Takada,Y. Yamashita,T. Kawamoto,M. Nishida,M. Ishigami,M. Hori,I. Shimomura,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 9, No. 1, p. 27-28, 2008/05
  • ADIPONECTIN ENHANCES APOA-1-AND HDL-MEDIATED CHOLESTEROL EFFLUX FROM HUMAN MONOCYTE-DERIVED MACROPHAGES, K. Yamamoto,M. Koseki,F. Matsuura,H. Oku,J. Sandoval,M. Kawase,D. Masuda,M. Nishida,M. Ishigami,K. Hirano,S. Kihara,M. Hori,I. Shimomura,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 9, No. 1, p. 52-52, 2008/05
  • Contribution of Cdc42 to cholesterol efflux in fibroblasts from Tangier disease and Werner syndrome, Ken-ichi Hirano,Chiaki Ikegami,Zhongyan Zhang, SMALL GTPASES IN DISEASE, PT B, ELSEVIER ACADEMIC PRESS INC, Vol. 439, p. 159-169, 2008
  • Adiponectin enhanced ApoA-1-and HDL - mediated cellular cholesterol efflux from human monocyte-derived macrophages, Masahiro Koseki,Kazumi Tsubakio-Yamamoto,Fumihiko Matsuura,Hiroyuki Oku,Jose C. Sandoval,Miyako Yuasa-Kawase,Daisaku Masuda,Makoto Nishida,Masato Ishigami,Ken-Ichi Hirano,Shinji Kihara,Masatsugu Hori,Lichiro Shimomura,Shizuya Yamashita, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 116, No. 16, p. 160-161, 2007/10
  • Impaired efflux of cholesterol from aged cells and its molecular mechanism: A basis for age-related enhancement of atherosclerosis, Shizuya Yamashita,Ken-Ichi Hirano,Zhongan Zhang,Kosuke Tsukamoto,Daisaku Masuda,Masahiro Koseki,Fumihiko Matsuura,Masato Ishigami,Makoto Nishida,Iichiro Shimomura, GERIATRICS & GERONTOLOGY INTERNATIONAL, WILEY, Vol. 7, No. 3, p. 205-214, 2007/09
  • Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor alpha secretion in Abca1-deficient macrophages, M. Koseki,K. Hirano,D. Masuda,Z. Zhang,J. C. Sandoval,Y. Nakagawa-Toyama,H. Oku,C. Ikegami,M. Kawase,K. Yamamoto,Y. Ohno-Iwashita,F. Matsuura,M. Nishida,M. Ishigami,I. Shimomura,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 8, No. 1, p. 82-83, 2007/06
  • Adiponectin protects against atherosclerosis by increasing cholesterol efflux from macrophages, K. Yamamoto,M. Koseki,R. Matsuura,C. Ikegami,H. Oku,S. J. Carlos,M. Kawase,D. Masuda,M. Nishida,M. Ishigami,K. Hirano,S. Kihara,I. Shimomura,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 8, No. 1, p. 14-14, 2007/06
  • Strategy for "raising HDL"; HDL-cholesterol or HDL particle numbers insight from cholesteryl ester transfer protein deficiency, Ken-ichi Hirano,Shizuya Yamashita,Masatsugu Hori, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 42, p. S222-S222, 2007/06
  • Postprandial hypertriglyceridemia in CD36 deficiency is caused by an accelerated lipoprotein synthesis in the small intestines, D. Masuda,K. Hirano,Y. Tochino,C. Ikegami,H. Oku,J. C. Sandoval,M. Kawase,K. Yamamoto,M. Koseki,F. Matsuura,M. Nishida,M. Ishigami,I. Shimomura,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 8, No. 1, p. 27-27, 2007/06
  • Cd36 deficiency is associated with phenotypes of the metabolic syndrome and enhanced atherosclerotic cardiovascular diseases, M. Kawase,D. Masuda,K. Hirano,C. Ikegami,H. Oku,J. C. Sandoval,K. Yamamoto,M. Takada,Y. Ishikawa,M. Kirino,M. Koseki,F. Matsuura,M. Yamane,M. Nishida,M. Ishigami,I. Shimomura,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 8, No. 1, p. 143-143, 2007/06
  • Adiponectin accelerates reverse cholesterol transport by increasing HDL assembly through upregulation of ABCA1 pathway and APOA-I synthesis in the liver, F. Matsuura,M. Koseki,Y. Oku,C. Ikegami,M. Kawase,K. Yamamoto,D. Masuda,M. Nishida,M. Ishigami,K. Hirano,S. Kihara,I. Shimomura,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 8, No. 1, p. 19-20, 2007/06
  • Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients, Shizuya Yamashita,Ken-ichi Hirano,Takahiro Kuwasako,Mohamed Janabi,Yumiko Toyama,Masato Ishigami,Naohiko Sakai, MOLECULAR AND CELLULAR BIOCHEMISTRY, SPRINGER, Vol. 299, No. 1-2, p. 19-22, 2007/05
  • 重症心不全に合併した急性感染性心内膜炎に免疫グロブリン製剤が有効であった一症例, 樋口 義治,松尾 浩志,種池 学,中谷 大作,坂田 泰史,坂田 泰彦,平野 賢一,大津 欣也,堀 正二, Medical Postgraduates, 医学書房(田辺三菱製薬(株)), Vol. 45, No. 1, p. 47-50, 2007/01
  • CD36 deficiency is a monogenic form of the metabolic syndrome and its macrophages exhibit atherogenic profiles, Daisaku Masuda,Ken-ichi Hirano,Yoshihiro Tochino,Takahiro Kuwasako,Chiaki Ikegami,Masahiro Koseki,Yumiko Nakagawa-Toyama,Fumihiko Matsuura,Iichiro Shimomura,Masatsugu Hori,Shizuya Yamashita, JOURNAL OF HYPERTENSION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 24, p. 162-162, 2006/12
  • Fasting serum apolipoprotein B-48 level can be a good marker of postprandial hyperlipidemia and coronary heart disease, S. Yamashita,T. Sugimoto,K. Hirano,M. Hori,Y. Masuda,T. Okuno,Y. Uchida,K. Matsumoto,T. Kawamoto,N. Sakai, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 7, No. 3, p. 511-511, 2006/06
  • Defective cholesterol efflux increased lipid rafts and enhanced lipopolysaccharide-induced cytokine release, M. Koseki,K. Hirano,D. Masuda,Z. Zhang,C. Ikegami,Y. Nakagawa-Toyama,Y. Ohno-Iwashita,I. Shimomura,M. Hori,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 7, No. 3, p. 237-237, 2006/06
  • Probucol stabilizes hepatic scavenger receptor class B type I possibly through species-specific fashion, K. Hirano,C. Ikegami,K. Tsujii,Z. Zhang,F. Matsuura,Y. Nakagawa-Toyama,M. Koseki,D. Masuda,Y. Ueda,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 7, No. 3, p. 575-575, 2006/06
  • Cholesterol levels in remnant lipoproteins determined by three different methods and their relations to visceral fat accumulation, M. Okazaki,S. Usui,M. Nara,T. Katsumata,A. Hashimoto,K. Hirano,M. Ishigami,M. Nishida,S. Yamashita, CLINICAL CHEMISTRY, AMER ASSOC CLINICAL CHEMISTRY, Vol. 52, No. 6, p. A119-A119, 2006/06
  • Familial intrahepatic cholestasis 1 gene product, a novel contributor for cholesterol efflux, K. Hirano,Y. Nakagawa-Toyama,A. Ota,Z. Zhang,C. Ikegami,K. Tsukamoto,M. Koseki,D. Masuda,M. Nishida,S. Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 7, No. 3, p. 28-28, 2006/06
  • Pitavastatin improved postprandial hypertriglyceridemia caused by the accelerated intestinal lipid absorption in CD36 deficiency, D. Masuda,K. Hirano,Y. Tochino,T. Kuwasako,C. Ikegami,M. Koseki,Y. Nakagawa-Toyama,Z. Zhang,I. Shimomura,S. Yamasita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER IRELAND LTD, Vol. 7, No. 3, p. 510-510, 2006/06
  • SI-HDL、小腸由来高比重リポ蛋白の分析 抗動脈硬化作用への期待, 増田 大作,平野 賢一,小関 正博,池上 千秋,大田 明生,清野 詩子,三井田 孝,下村 伊一郎,山下 静也, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 6回, p. 99-99, 2006/05
  • Increased chylomicron remnants (CR) in diabetic patients in relation to coronary heart disease (CHD) - analysis by a novel ELISA for apo B-48, S Yamashita,T Sugimoto,K Tsujii,M Koseki,D Masuda,Y Toyama,K Hirano,Y Uchida,N Sakai, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 39, No. 6, p. 1020-1021, 2005/12
  • Probucol enhances the expression of human hepatic scavenger receptor class B type I possibly through species-specific mechanism, K Hirano,C Ikegami,K Tsujii,M Koseki,D Masuda,Y Nakagawa-Toyama,Y Ueda,Shimomura, I,S Yamashita,M Hori, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 39, No. 6, p. 1005-1005, 2005/12
  • Deficiency of a multi-ligand receptor CD36 is associated with insulin resistance and the metabolic syndrome, S Yamashita,D Masuda,T Kuwasako,M Janabi,Y Toyama,K Hirano,N Sakai,M Hori, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 39, No. 6, p. 1005-1005, 2005/12
  • Fasting serum apolipoprotein B-48 level is a good marker of postprandial hyperlipidemia and coronary heart disease, S Yamashita,T Sugimoto,K Hirano,M Hori,Y Masuda,A Ikeda,T Okuno,Y Uchida,K Matsumoto,T Kawamoto,N Sakai, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 39, No. 6, p. 1003-1003, 2005/12
  • Accelerated intestinal absorption of dietary lipids causes postprandial hypertriglyceridemia in CD36 knockout mice, D Masuda,K Hirano,T Kuwasako,C Ikegami,M Koseki,Y Nakagawa-Toyama,ZY Zhang,Y Tochino,M Hori,S Yamashita, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 39, No. 6, p. 1003-1004, 2005/12
  • A novel cellular phenotype of macrophages with deficiency of atp-binding cassette transporter-A1 (ABCA1), M Koseki,K Hirano,D Masuda,ZY Zhang,C Ikegami,Y Nakagawa-Toyama,Y Shimada,Y Ohno-Iwashita,T Kobayashi,S Sato,Shimomura, I,M Hori,S Yamashita, JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, Vol. 39, No. 6, p. 1033-1033, 2005/12
  • 冠動脈硬化症を早期に合併したシトステロール血症の1症例(第99回日本循環器学会近畿地方会), 松村 梨紗,光定 伸浩,奥本 泰士,中川 靖彦,辻井 健一,松山 晃文,平野 賢一,中村 正,山下 静也, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 69, No. 0, 2005/10/20
  • 小腸由来高比重リポ蛋白 新しい粥状動脈硬化治療標的として, 増田 大作,平野 賢一,清野 詩子,小関 正博,Zhang Zhongyan,池上 千秋,下村 伊一郎,三井田 孝,山下 静也, 日本抗加齢医学会総会プログラム・抄録集, (一社)日本抗加齢医学会, Vol. 5回, p. 55-55, 2005/06
  • Vesicular acidification is required for ATP-bindig cassette transporter A1-mediated phospholipid and cholesterol efflux, A Matsuyama,N Sakai,M Koseki,T Ohama,K Hirano,H Hiraoka,S Yamashita, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, Vol. 5, No. 1, p. 76-76, 2004/04
  • シトステロール血症の一例, 平野賢一,小関正博,松山晃文ほか, The Lipid, Vol. 15, p. 85-88, 2004
  • Low and high HDL syndrome, Hirano K,Yamashita S,Sakai N,Matsuzawa Y, Vol. 3, p. 199-205, 2004
  • Identification of a novel mutation in the ATP-binding cassette transporter G5 (ABCG5) in a Japanese patient with sitosterolemia, M Koseki,A Matsuyama,M Ishigami,K Hirano,N Sakai,H Hiraoka,T Nakamura,H Hattori,M Nagano,T Egashira,S Yamashita,Y Matsuzawa, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, Vol. 4, No. 2, p. 138-138, 2003/09
  • Effects of atorvastatin on remnant lipoprotein metabolism in type III hyperlipoproteinemia - Comparison with fenofibrate, M Ishigami,S Yamashita,N Sakai,K Hirano,H Hiraoka,T Nakamura,Y Matsuzawa, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, Vol. 4, No. 2, p. 161-161, 2003/09
  • Vesicular acidification is required for ATP-binding cassette transporter A1-mediated cholesterol efflux, A Matsuyama,N Sakai,M Koseki,Y Nishida,T Ohama,K Hirano,H Hiraoka,S Yamashita,Y Matsuzawa, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, Vol. 4, No. 2, p. 135-135, 2003/09
  • Cdc42, a RhoGTPase, restores defective cholesterol efflux in Werner syndrome fibroblasts, Z Zhang,K Hirano,K Tsukamoto,K Saijo,K Tsujii,T Ohhama,T Ohno,S Yamashita,Y Matsuzawa, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, Vol. 4, No. 2, p. 68-68, 2003/09
  • Dominant expression of ATP binding cassette transporter A1 on basolateral surface of human intestinal epithelium, T Ohama,K Hirano,Z Zhang,K Tsujii,Y Nakagawa-Toyama,A Matsuyama,M Ishigami,N Sakai,H Hiraoka,K Ueda,S Yamashita,Y Matsuzawa, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, Vol. 4, No. 2, p. 136-136, 2003/09
  • Postprandial hyperlipidemia and increased remnant lipoproteins in human genetic CD36 deficiency, T Kuwasako,K Hirano,N Sakai,M Ishigami,H Hiraoka,S Yamashita,Y Matsuzawa, ATHEROSCLEROSIS SUPPLEMENTS, ELSEVIER SCI IRELAND LTD, Vol. 4, No. 2, p. 226-227, 2003/09
  • Pathophysiology of human genetic CD36 deficiency, K Hirano,T Kuwasako,Y Nakagawa-Toyama,M Janabi,S Yamashita,Y Matsuzawa, TRENDS IN CARDIOVASCULAR MEDICINE, ELSEVIER SCIENCE LONDON, Vol. 13, No. 4, p. 136-141, 2003/05
  • 175)ミトコンドリア心筋症の1例, 千森 義浩,大村 素子,中島 忠久,松山 晃文,西田 誠,平野 賢一,平岡 久豊, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 67, No. 0, 2003/04/20
  • タンジール病, 低HDL血症とABCA1, 平野 賢一, Vol. 20, No. 1, p. 83-89, 2003
  • ヒト粥状硬化病変におけるコレステリンエステル移送蛋白とコレステロール逆輸送の意義(Expression of Cholesteryl Ester Transfer Protein in Human Atherosclerotic Lesions and Its Implication in Reverse Cholesterol Transport), 張 仲衍,山下 静也,平野 賢一,外山 裕美子,松山 晃文,西田 誠,酒井 尚彦,新井 洋由,宮川 潤一郎,松澤 佑次, 動脈硬化, (一社)日本動脈硬化学会, No. 34回抄集, p. 195-195, 2002/06
  • 95)ミノサイクリンが有効であった大動脈炎症候群の1例(日本循環器学会 第92回近畿地方会), 平田 歩,松山 晃文,樫根 晋,石神 眞人,平野 賢一,平岡 久豊,中村 正,山下 静也,松澤 佑次, Circulation journal : official journal of the Japanese Circulation Society, 社団法人日本循環器学会, Vol. 66, No. 0, 2002/04/20
  • タンジール病解析より明らかになってきた細胞内脂質輸送およびコレステロール引き抜きの分子機構, 平野 賢一, The Lipid, Vol. 13, No. 2, p. 183-190, 2002
  • CD36 deficiency and insulin resistance [5] (multiple letters), John R. Petrie,Mary Collison,John M. Connell,Gwyn W. Gould,Anna F. Dominiczak,Yoko Iizuka,Takanari Gotoda,Shun Ishibashi,Nobuhiro Yamada,Hitoshi Chiba,Hidekatsu Yanai,Hironobu Fujiwara,Kazuhiko Matsuno,Kunihiko Kobayashi,Ken-Ichi Hirano,Takahiro Kuwasako,Hirokazu Kashiwagi,Shizuya Yamashita,Yuji Matsuzawa, Lancet, Vol. 358, No. 9277, p. 242-244, 2001/07/21
  • HDL代謝異常症の解析によるコレステロール引き抜きの分子機構の解明 : タンジール病細胞における低分子量G蛋白 Cdc42の発現異常と病態との関連, 平野 賢一,塚本 幸資,張 仲衍,松浦 文彦,辻井 健一,松山 晃文,池上 千秋,酒井 尚彦,山下 静也,松澤 佑次, 動脈硬化 = The journal of Japan Atherosclerosis Society, Vol. 29, 2001/05/15
  • Roles of plasma lipid transfer proteins in reverse cholesterol transport, S Yamashita,N Sakai,K Hirano,M Ishigami,T Maruyama,N Nakajima,Y Matsuzawa, FRONTIERS IN BIOSCIENCE, FRONTIERS IN BIOSCIENCE INC, Vol. 6, p. D366-D387, 2001/03
  • コレステロール逆転送系の分子機構とその異常, 平野 賢一, 血管, Vol. 24, No. 3, p. 137-140, 2001
  • Tangier病, 平野 賢一, 症例に学ぶ高脂血症治療 専門医のみるポイント48+α, p. 75-79, 2001
  • CD36欠損症 インスリン抵抗性の遺伝的素因の1つとして, 平野 賢一, Diabetes Journal: 糖尿病と代謝, Vol. 29, p. 111-115, 2001
  • CD36, 平野 賢一, 日本臨床, Vol. 59, No. 増刊2 高脂血症(上), p. 349-354, 2001
  • タンジール病とABC蛋白, 平野 賢一, 日本臨床, Vol. 59, No. 増刊3 高脂血症(下), p. 846-852, 2001
  • コレステロールエステル転送蛋白の病態生理学的意義, 平野賢一,松澤佑次, 内分泌・糖尿病科, Vol. 12, No. 2, p. 137-147, 2001
  • Pros and cons of inhibiting cholesteryl ester transfer protein, K Hirano,S Yamashita,Y Matsuzawa, CURRENT OPINION IN LIPIDOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 11, No. 6, p. 589-596, 2000/12
  • Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia, S Yamashita,T Maruyama,K Hirano,N Sakai,N Nakajima,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 152, No. 2, p. 271-285, 2000/10
  • 0416 ヒト単球由来MφにおけるGPI-anchor型HDL結合蛋白の精製, 松山 晃文,酒井 尚彦,平野 賢一,山下 静也,松澤 佑次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, No. 0, 2000/03/01
  • 0418 HDL欠損症(Tangier病)より見出した動脈硬化関連遺伝子の異常発現とその分子機構 : 低分子量G蛋白CDC42と細胞内mRNAの安定性について, 松浦 文彦,平野 賢一,山下 静也,松山 晃文,小室 竜太郎,松澤 佑次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, No. 0, 2000/03/01
  • 0954 Cholesterol effluxエンハンサー分子の発見 : ヒト単球由来マクロファージよりのScavenger Receptor Class B Type I(SRBI)の新規変異体,SR-BIIIのクローニングとその機能解析, 平野 賢一,松山 晃文,塚本 幸資,山下 静也,松澤 佑次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, No. 0, 2000/03/01
  • 0956 プロブコールによるHDL受容体、SR-BI(Scavenger receptor class B type I)の発現増強 : in vivo(ウサギ)およびin vitro(Hep G2)における検討, 辻井 健一,平野 賢一,松浦 文彦,中川 裕美子,松山 晃文,山下 静也,松沢 佑次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, No. 0, 2000/03/01
  • 0958 タンジール病患者解析より発見した高比重リポ蛋白(HDL)によるコレステロール引き抜き(Cholesterol Efflux,CE)の分子機構 : 低分子量G蛋白、Cdc42のCEにおける意義, 平野 賢一,松浦 文彦,松山 晃文,塚本 幸資,山下 静也,松澤 佑次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 64, No. 0, 2000/03/01
  • タンジール病(TD)患者解析より発見した高比重リポ蛋白(HDL)によるコレステロール引き抜き(Cholesterol Efflux,CE)の分子機構 低分子量G蛋白,Cdc42のCEにおける意義, 平野賢一,松浦文彦,松山晃文,塚本幸資,高石健司,山下静也,高井義美,松沢佑次, 日本内科学会雑誌, Vol. 89, 2000/02/20
  • HDLと動脈硬化, 目でみる循環器病シリーズ15 冠危険因子, p. 42-50, 2000
  • コレステロール逆転送系の分子機構とその異常, 平野 賢一, CARDIAC PRACTICE, Vol. 11, p. 41-47, 2000
  • Application of a sandwich ELISA for apo B48 and immunohistochemical detection of apo B48 in human atherosclerotic aorta, S Yamashita,Y Saika,M Nishida,Y Nakagawa,K Hirano,N Sakai,J Miyagawa,Y Matsuzawa, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, No. 18, p. 330-330, 1999/11
  • Cloning and expression of a novel splice form of human scavenger receptor class B type I (SR-BI) which has a single putative transmembrane domain at the carboxy terminus and is expressed exclusively in differentiated macrophages, K Hirano,K Tsukamoto,S Yamashita,C Hoson,A Matsuyama,Y Matsuzawa, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, No. 18, p. 37-37, 1999/11
  • 高度な動脈硬化を呈した高HDL血症の2例, 伏見 悦子,中村 保宏,山中 多聞,高橋 俊明,関口 展代,渡辺 一,林 雅人,丸山 貴生,平野 賢一,酒井 尚彦, Japanese Circulation Journal, (一社)日本循環器学会, Vol. 63, No. 2, p. 699-699, 1999/08/20
  • 1088 動脈硬化防御機構、コレステロール逆転送系の賦活 : プロブコールによる高比重リポ蛋白(HDL)受容体CLA-1(CD36 and LIMPII Analogous-1)の発現増強, 辻井 健一,平野 賢一,松浦 文彦,中川 裕美子,松山 晃文,山下 静也,松澤 祐次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 63, No. 1, 1999/03/01
  • P785 ヒト単球由来マクロファージよりのCD36/LIMPII Analogous-1(CLA-1)のクローニングと分化に伴う発現誘導, 平野 賢一,中川 裕美子,大屋 健,塚本 幸資,松浦 文彦,岡本 芳久,松本 健吾,松山 晃文,宮川 潤一郎,山下 静也,松澤 佑次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 63, No. 1, 1999/03/01
  • 多機能受容体、CD36の生理学的意義の検討 ―CD36欠損症と高トリグルセリド血症との関連―, 平野賢一,野崎秀一,松本健吾,Janabi Mohamed,中川裕美子,冨山佳昭,山下静也,松澤佑次, 日本臨床分子医学会記録, Vol. 36, 1999
  • Expression of CLA-1 (CD36 and LIMP II analogous-1) in cultured human monocyte-derived macrophages and in human atherosclerotic lesions, K Hirano,Y Nakagawa,T Ohya,A Takamoto,A Matsuyama,Y Okamoto,K Matsumoto,F Matsuura,N Sakai,J Miyagawa,S Yamashita,Y Matsuzawa, CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 98, No. 17, p. 108-109, 1998/10
  • P296 HDLの坑動脈硬化作用の分子機構 : FITC標識HDLを用いたHDLの細胞内動態の検討, 松山 晃文,酒井 尚彦,辻井 健一,松浦 文彦,丸山 貴生,平野 賢一,山下 静也,松沢 佑次, Japanese circulation journal, 社団法人日本循環器学会, Vol. 62, No. 0, 1998/02/28
  • Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E-Suita), K Yanagi,S Yamashita,H Hiraoka,M Ishigami,S Kihara,K Hirano,N Sakai,S Nozaki,T Funahashi,K KamedaTakemura,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 134, No. 1-2, p. 381-381, 1997/10
  • Mutational analysis of hyperalphalipoproteinemia (HALP) in the Japanese: Cholesteryl ester transfer protein deficiency contributes about 60% of marked HALP, T Maruyama,S Yamashita,N Sakai,K Hirano,T Arai,M Ishigami,Y Matsuzawa, ATHEROSCLEROSIS, ELSEVIER SCI IRELAND LTD, Vol. 134, No. 1-2, p. 370-370, 1997/10
  • 高HDL血症のatherogenicityに関する検討 コレステリルエステル転送蛋白(CETP)と肝性リパーゼ(HTGL)両者の低下した高HDL血症のatherogenicity, 平野賢一,山下静也,松澤佑次, The Lipid, Vol. 7, No. 4, p. 404-408, 1996
  • Molecular disorders of cholesteryl ester transfer protein, Yamashita S,Arai T,Hirano K,Sakai N,Ishigami M,Nakajima N,Matsuzawa Y, J Atheroscler Thromb, Vol. 3, No. 1, p. 1-11, 1996
  • MARKED HYPERALPHALIPOPROTEINEMIA (HALP) DUE TO A COMBINED REDUCTION IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) AND HEPATIC TRIGLYCERIDE LIPASE (HTGL) IS ACCOMPANIED BY ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE (ACD), S YAMASHITA,K HIRANO,M ISHIGAMI,T ARAI,N SAKAI,S NAZAKI,K TAKEMURA,Y MATSUZAWA, CIRCULATION, AMER HEART ASSOC, Vol. 90, No. 4, p. 510-510, 1994/10
  • FREQUENCY OF THE COMMON CHOLESTERYL ESTER TRANSFER PROTEIN GENE MUTATION IN THE JAPANESE POPULATION, K HIRANO,S YAMASHITA,N SAKAI,T FUNAHASHI,K TOKUNAGA,Y MATSUZAWA, CIRCULATION, AMER HEART ASSOC, Vol. 86, No. 4, p. 72-72, 1992/10
  • 症例検討 脂質代謝異常症に関して CETP欠損症, 平野賢一,酒井尚彦,山下静也,松澤佑次, The Lipid, Vol. 2, No. 5, p. 519-524, 1991
  • MARKED HYPERALPHALIPOPROTEINEMIA IN CHRONIC ALCOHOL DRINKERS WITH REDUCED CHOLESTERYL ESTER TRANSFER ACTIVITY, K HIRANO,N SAKAI,H HIRAOKA,T FUNAHASHI,S NOZAKI,S YAMASHITA,M KUBO,Y MATSUZAWA,S TARUI, CIRCULATION, AMER HEART ASSOC, Vol. 82, No. 4, p. 282-282, 1990/10
  • MARKED HYPERALPHALIPOPROTEINEMIA IN CHRONIC ALCOHOL DRINKERS WITH REDUCED CHOLESTERYL ESTER TRANSFER ACTIVITY, K HIRANO,N SAKAI,H HIRAOKA,T FUNAHASHI,S NOZAKI,S YAMASHITA,M KUBO,Y MATSUZAWA,S TARUI, ARTERIOSCLEROSIS, AMER HEART ASSOC, Vol. 10, No. 5, p. A764-A764, 1990/09
  • DETECTION OF 2 SPECIES OF LDL PARTICLES IN CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) DEFICIENCY, N SAKAI,Y MATSUZAWA,K HIRANO,S YAMASHITA,S NOZAKI,Y UEYAMA,M KUBO,S TARUI, ARTERIOSCLEROSIS, AMER HEART ASSOC, Vol. 10, No. 5, p. A851-A851, 1990/09
  • 高脂血症 病態生化学からみた診療の進めかた 高HDL血症, 平野賢一,酒井尚彦,山下静也,松澤佑次, Medical Practice, Vol. 7, No. 3, p. 421-424, 1990
  • 高HDL血症とコレステロール逆転送, 平野賢一,酒井尚彦,平岡久豊,山下静也,松澤佑次, Therapeutic Research, Vol. 11, No. 10, p. 3296-3300, 1990
  • リポ蛋白代謝 LTP(脂質転送蛋白), 平野賢一,酒井尚彦,松澤佑次, The Lipid, Vol. 1, No. 3, p. 54-59, 1990
  • CHARACTERIZATION OF LDL PARTICLES FROM PATIENTS WITH DEFICIENCY OF CHOLESTERYL ESTER TRANSFER PROTEIN (CETP), N SAKAI,Y MATSUZAWA,S YAMASHITA,K HIRANO,Y UEYAMA,M KUBO,S TARUI, ARTERIOSCLEROSIS, AMER HEART ASSOC, Vol. 9, No. 5, p. A761-A761, 1989/09

Awards

  • 平成27年 大阪大学総長顕彰, 平野 賢一, 大阪大学, 2015/07
  • 平成26年 大阪大学総長顕彰, 平野 賢一, 大阪大学, 2014/07
  • 第30回心筋生検研究会 最優秀演題賞, 2008
  • AstraZeneca Research Grant 2003, 2003
  • 平成13年 第14回 日本内科学会奨励賞, 2001
  • 平成12年 第37回 日本臨床分子医学会学術奨励賞, 2000
  • 平成12年 日本循環器学会 第17回 Young Investigator's Award (YIA), 2000
  • 平成12年 第8回 日本動脈硬化学会 若手研究者奨励賞最優秀賞, 2000
  • 平成12年 第5回 日本心臓財団 高血圧と血管代謝研究助成 最優秀賞, 2000
  • 岡本研究奨励賞, 1999
  • 成人血管病研究振興財団 岡本研究奨励賞, 1999